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ABSTRACT 
Trypanosoma congolense is a single-cell blood parasite and an important 
pathogen causing African trypanosomiasis, also called n’gana, in livestock. N’gana in 
cattle is a chronic disease associated with anemia, cachexia and increased susceptibility 
to secondary infections. Infection of mice can be used as an experimental model to study 
the host-parasite relationship. As determined by their survival time, BALB/c mice are 
highly susceptible to T. congolense infection, whereas C57BL/6 mice are relatively 
resistant. The surfaces of African trypanosomes are covered with a layer of a single 
species of glycoprotein, called variant surface glycoprotein (VSG). Production of 
antibodies to the VSG of African trypanosomes is one of the major immune responses 
leading to control of parasitemia. The reaction of antibodies with VSG of trypanosomes, 
for presently unknown reasons, predominantly activates the alternative complement 
pathway rather than the clasical pathway of complement. IgM antibodies are the first 
and predominant class of anti-trypanosomal antibodies in infected animals. Antibody-
mediated phagocytosis of T. congolense by macrophages is considered a major 
mechanism of control of parasitemia, besides antibody/complement-mediated lysis and 
cytotoxic effect by macrophage-derived nitric oxide (NO). The receptor(s) on 
macrophages that recognizes IgM antibody-coated trypanosomes and enables their 
phagocytosis is unknown. Interaction of antibodies with the VSG of trypanosomes not 
only causes phagocytosis of trypanosomes by macrophages, but also leads to the release 
of sVSG from the trypanosomes. sVSG has been found to modulate various functions of 
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the host: induction of polyclonal B cell activation and modulation of macrophage 
functions, such as the induction of TNF-α synthesis and the inhibition of IFN-γ-induced 
nitric oxide production. The objectives of this thesis are:  
1) to test whether CR3 (Mac-1; CD11b/18) is involved in IgM anti-VSG-mediated 
phagocytosis of T. congolense by macrophages,  
2) to test the effects of anti-VSG antibody and complement on the release of soluble 
VSG from T. congolense 
1) When the trypanosomes were incubated with IgM anti-VSG antibody and fresh 
mouse serum, fragments of complement component C3 were found to be deposited onto 
Trypanosoma congolense. Thus, it was assessed whether complement receptor CR3 
(CD11b/CD18; receptor for iC3b) might be involved in IgM anti-VSG mediated 
phagocytosis of T. congolense. In the presence of fresh mouse serum, there was 
significantly and markedly less phagocytosis of IgM-opsonized T. congolense by 
CD11b-deficient macrophages compared to phagocytosis by normal macrophages (78% 
fewer T. congolense were ingested per macrophage). There also was significantly less 
TNF-α (38% less), but significantly more NO (63% more) secreted by CD11b-deficient 
macrophages that had engulfed trypanosomes than by equally treated normal 
macrophages. It was concluded that CR3 is the major, but not the only, receptor 
involved in IgM anti-VSG-mediated phagocytosis of T. congolense by macrophages. It 
was further concluded that signaling via CR3, associated with IgM anti-VSG-mediated 
phagocytosis of T. congolense, either directly or indirectly, enhances synthesis of 
disease-producing TNF-α and inhibits the synthesis of parasite-controlling NO. 
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2) This investigation revealed that there was more sVSG released from T. 
congolense by interaction with IgM anti-VSG than by interaction with equal amounts of 
IgG2a anti-VSG. The release of sVSG occurred in an antibody dose-dependent pattern. 
It was also found that IgM anti-VSG, after interacting with the surface of T. congolense, 
formed soluble immune complexes with released sVSG. The results also showed that 
antibody-induced release of sVSG can occur without complement, but is enhanced by 
complement. It was further tested whether fresh sera from either relatively resistant 
C57BL/6 mice or highly susceptible BALB/c mice, which differ in their complement 
cascade, had different effects on the release of sVSG from T. congolense. The results 
showed that antibody-induced shedding of sVSG was higher in the presence of fresh 
C57BL/6 serum than in the presence of fresh BALB/c serum. All these data suggest that 
the concentration of anti-VSG antibody, antibody class and source of complement can 
affect the release of sVSG from T. congolense. 
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1. LITERATURE REVIEW 
1.1 African Trypanosomes 
1.1.1 Introduction 
African trypanosomes are extracellular parasites causing sleeping sickness in 
humans and a disease called nagana in livestock. The main trypanosome species 
responsible for the livestock disease are Trypanosoma congolense, T. vivax and T. brucei 
brucei. Of these species, T. congolense is the most virulent pathogen causing the greatest 
losses in livestock (Mulligan & Potts, 1970). 
Trypanosome species are mainly transmitted to their mammalian hosts by tsetse 
flies, which inhabit regions between latitudes 14oN and 29oS. About 10 million square 
kilometers and 37 countries are covered in this tsetse fly “belt”, a geographical area 
equivalent to the combined size of the United States, India and Western Europe (Hursey 
& Slingenbergh, 1995). 
African trypanosomes are responsible for large economic losses in the livestock-
based cultures and economies of Africa. The direct production loss only in cattle was 
estimated to be between US$ 6,000 million to US$ 12,000 million per year (Hursey & 
Slingenbergh, 1995). If the disease would be controlled, the region could support a 
further 120 million cattle annually (Nantulya, 1986). Trypanosomiasis control has a long 
history. Several methods have been employed. The primary approach to disease control 
is to halt transmission by controlling the insect vectors: the tsetse flies. This has been 
done by the removal of reservoir hosts (game animals), destruction of tsetse habitat 
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(bush clearing) and spraying with residual formulations of suitable insecticides 
(Schofield & Maudlin, 2001). But these measures can result in ecological and 
environmental problems. Chemotherapy is another measure for controlling 
trypanosomiasis. The first trypanocidal drug was developed in 1905 (Seed, 2001), but 
the number of drugs available for the treatment of African trypanosomiasis is very 
limited. In addition, drug resistance reduces the efficacy of chemotherapy and such 
resistance is becoming increasingly prevalent (De Koning, 2001, Seed, 2001). 
Vaccination has been considered to be one of the measures for control, but antigenic 
variation represents a formidable obstacle that reduces the likelihood of developing an 
effective VSG-based vaccine. Thus, invariant parasite molecules that are either 
expressed on the parasite surface or that mediate pathogenesis are being considered as 
candidates for vaccine design (Taylor, 1998). So far these vaccines only show minimal 
protection. It is clear that vaccine design has to be based on a better understanding of the 
immune responses provoked by infection and of the mechanisms involved in either 
parasite or disease control.  
 
1.1.2 Classification 
Trypanosomes are a genus of protozoa belonging to the family Trypanosomatidae, 
order Kinetoplastida, class Zoomastigophores. The pathogenic trypanosomes belong to 
the subgenus Trypanosoma, and the species of mammalian trypanosomes fall naturally 
into two major sections characterized by the mode of their development primarily in the 
vector and secondarily in the mammalian host (Hoare, 1972, Vickerman, 1976) 
A. Section Salivaria:  The developmental cycle of the salivarian species in the 
insect-vector is completed in the salivary glands. The parasites are transmitted to the 
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mammalian host by the bite of the infected insect vector during a blood meal. Most 
species of this section are important pathogens either in man or domestic animals. This 
section contains 4 groups: Duttonella, Nannomonas, Trypanozoon and Pycnomonas. 
The constitution of these groups is more homogenous than that of the stercoraria (Hoare, 
1972, Vickerman, 1976). 
B. Section Stercoraria: The developmental cycle of these species in the insect 
vector is completed in the fecal medium of the gut, such that transmission occurs by 
contamination of lesions or wounds produced by scratching the skin in response to 
irritation of the insect’s bite. This section contains three subgroups: Megatrypanum, 
Herpestoma and Schizotrypanum (Hoare, 1972, Vickerman, 1976). 
Table 1.1 Classification of mammalian trypanosomes (Hoare, 1972, Vickerman, 1976) 
Section  Salivaria Stercoraria 
Subgenus 
and species 
Subgenus: Duttonella 
   Species: Trypanosoma vivax 
Subgenus: Nannomonas 
   Species: Trypanosoma congolense,  
                 T. simiae 
Subgenus: Trypanozoon 
Species: Trypanosoma brucei,  
T.  rhodesiense,  
T.  gambiense,  
T.  evansi   
T.  equiperdum 
Subgenus: Pycnomonas 
Species: Trypanosoma suis 
Subgenus: Megatrypanum 
Species: Trypanosoma theileri  
Subgenus: Herpestoma 
Species: Trypanosoma lewisi and 
T. musculi 
Subgenus: Schizotrypanum 
Species: Trypanosoma cruzi 
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1.1.3 Morphology 
The characterization of African trypanosomes is based on their shape, size, and 
position of the nucleus, size and location of the kinetoplast, host range and geographical 
distribution. African trypanosomes are thoroughly adapted to living extracellularly in the 
blood plasma or tissue fluid of the host. They are elongated and streamlined, tapered at 
both ends, and range from 8-30 µm in length. A flagellum arises at the posterior end 
from the basal body adjacent to the kinetoplast, and runs the length of the trypanosome. 
The pellicle, the layer bordering the cytoplasm, while retaining a definite shape, is 
flexible enough to permit a degree of body movement. Along the length of the body, the 
pellicle and cytoplasm are pinched up into a thin sheet of tissue called the undulating 
membrane (Hoare, 1972). 
T. congolense is a small salivarian trypanosome that is about 13.4 µm to 15.8 µm 
long (Stephen, 1986). Its kinetoplast, which has important functions in reproduction and 
metabolism, has a marginal location and is medium-sized (Hoare, 1964). It is sluggish in 
its movements and has a central nucleus and an undulating membrane (Hoare, 1972, 
Soltys & Woo, 1987). 
 
1.1.4 Life Cycle 
The life cycle of African trypanosomes has two phases, one in the insect vector 
and another one in the mammalian host. 
Transmission is mediated by tsetse flies (Glossina species). There are more than 34 
species and subspecies of the genus Glossina that are recognized at the present time. 
They belong to three groups: fusca group (forest group), palpalis group (riverine group), 
  
5 
and morsitans group (savannah group). T. congolense is capable of developing in all 
these three groups (Hoare, 1972). The tsetse fly acquires a trypanosomal infection when 
feeding on an infected mammalian host. The ingested blood stream forms of 
trypanosomes lose their surface coat in the insect and undergo a cycle of development, 
in morphologic terms as well as in their metabolism. Ingested trypanosomes change into 
a longer, slender form called epimastigote. These epimastigotes multiply for about 3 
weeks and finally give rise to the infective metatrypanosomes. Metatrypanosomes re-
acquire their surface coat of variant surface glycoprotein (VSG) and thus regain 
infectivity for mammals. This occurs in the salivary glands (Hoare, 1972, Stephen, 
1986). The period from ingesting infected blood to the appearance of infective forms in 
the tsetse fly varies from 7 to 53 days (Hoare, 1972, Nantulya et al., 1978). The tsetse fly 
remains infective for the remainder of its life once infective metatrypanosomes are 
present.  Infections of the host occur when infected flies bite the host (Molyneux & 
Ashford, 1983). 
At the site of infection, a swelling or chancre may be detected in the skin that is 
caused by infective metatrypanosomes undergoing development and multiplication. 
Once the trypanosomes become mature, they are released via lymph vessels and lymph 
nodes into the blood circulation (Akol & Murray, 1982). Trypanosomes feed by 
absorbing nutrients from the body fluids of the host, and reproduction occurs through a 
process of binary division. The parasitemia in the peripheral blood usually becomes 
apparent in one or two weeks after natural infections. During the growth, trypanosomes 
vary from long slender forms that predominate in the early logarithmic growth phase of 
infection to short, stumpy and usually non-dividing forms, which are predominant in the 
phase of parasite remission (McLintock et al., 1990). The transformation from the long 
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slender form to the short stumpy form is essential for the vector transmissibility (Seed & 
Sechelski, 1989).  
 
1.1.5 Trypanosomal antigens 
The trypanosomal antigens can be divided into two groups. The first group 
includes the major surface protein of the bloodstream forms of African trypanosomes, 
named variant surface glycoprotein (VSG). The VSG form a major component of the 
12-15 nm thick electron dense “surface coat” covering trypanosomes. The layers of VSG 
serve as a protective coat for the parasites. VSG is an immunodominant antigen of the 
parasite. The major part of the host’s humoral immune response is directed against the 
VSGs (Cross, 1990), but some of the parasites survive by expressing a different VSG. 
The other group is called the non-variable or common antigens. They are the 
subcellular components, such as structural proteins, enzymes, and membrane 
constituents (Burgess & Jerrells, 1985, Frommel & Balber, 1987, Shapiro & Murray, 
1982). Some of these non-variable antigens may represent cell surface proteins, such as 
transporters (Parsons & Nielsen, 1990, Webster & Shapiro, 1990), or some enzymes like 
phospholipase C (Fox et al., 1986, Lamont et al., 1987), trypanosome heat shock protein 
60 (HSP60) (Radwanska et al., 2000), and even the C-terminal end of the surface 
glycoprotein (Rice-Ficht, 1981). These non-variable antigens are expected to remain 
conserved between trypanosome serodemes, or even different trypanosomatid species or 
genera (Muller et al., 1992, Olenick et al., 1988). 
The non-variant antigens are not exposed to the surface of the intact living 
trypanosomes, but they are released after parasite lysis by anti-VSG antibodies and 
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complement. These invariant antigens may play a role in the pathogenesis of the disease. 
It has been reported that antibody responses to cysteine protease (congopain) are 
associated with resistance in T. congolense-infected cattle (Authie et al., 1993), which 
suggests that the immune response to this common antigen may play a role in the 
relative susceptibility or resistance during trypanosome infection. 
 
1.1.6 Antigenic Variation 
African trypanosomes will periodically express a different VSG gene that is 
antigenically distinct from the previously expressed VSG with a switch rate of 10-3 to 
10-5 per cell generation (Cross, 1990). This is called antigenic variation. Each parasite is 
estimated to have some 1000 distinct VSG genes. The known function of the VSG is to 
serve as a protective barrier against the attack by the innate immune system on the other 
outer membrane constituents (El-Sayed et al., 2000, Ferrante & Allison, 1983). T. 
congolense and T. brucei brucei that lack surface coats are lysed via the alternative 
pathway of complement when incubated in normal serum, in contrast to the parasites 
which possessed a surface coat (El-Sayed et al., 2000, Ferrante & Allison, 1983). 
Because of antigen variation, the infected host develops a fluctuating chronic 
parasitemia and subsequent waves of VSG-specific antibodies. Antigenic variation 
permits the trypanosome population as a whole to keep “one step ahead ”of the immune 
response (El-Sayed et al., 2000). The frequent changes of VSG expression during 
infection and the genetic diversity of the VSGs are thought to represent strategies by 
African trypanosomes to evade the immune system of their mammalian hosts and to 
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permit survival of these organisms within the hosts (Kang et al., 2002, Mansfield et al., 
2000).   
 
1.1.7 Variant Surface Glycoprotein (VSG) 
1.1.7.1  Organization of the VSG Gene 
The African trypanosome genome contains about 1000 different VSG genes (Van 
der Ploeg et al., 1982). Under normal conditions one and only one VSG gene is 
expressed at a time in a given bloodstream parasite (Baltz et al., 1986, Esser & 
Schoenbechler, 1985, Munoz-Jordan et al., 1996). The unexpressed VSG genes are 
scattered among the different chromosomes, including the minichromosomes (Borst et 
al., 1998, Cross et al., 1998, Donelson, 1996, Pays & Nolan, 1998). In order to be 
transcribed, VSG genes need to be located in a specialized telomeric environment, 
which is known as a bloodstream telomere-linked VSG gene expression site (BES). 
Only a few expressed bloodstream VSG genes have been examined in detail, but all 
have been found to be transcribed from telomere-linked expression sites that typically 
consume 45-60 kb, and contain a VSG promoter, a variable number of 70-76 bp repeats, 
and the VSG gene is followed by subtelomeric and telomeric DNA repeats (Kang et al., 
2002). As BESs contain the only active VSG locus in trypanosomes living in the 
mammalian host, they are the sites of antigenic variation. At any time, only one BES is 
active and only one VSG gene is transcribed (El-Sayed et al., 2000).  
There are two possible mechanisms by which VSG expression can be changed, 
leading to antigenic variation. They can either switch expression between BESs 
(telomere conversion) or replace the VSG gene within the active BES (duplicative 
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transposition). Both mechanisms have been observed (Vanhamme et al., 2001). The 
molecular events in a given trypanosome that induce transcription at one BES and 
silence expression at the other BESs are not understood (El-Sayed et al., 2000). 
 
1.1.7.2 Structure of VSG 
Variant surface glycoprotein (VSG) is the major component of trypanosomes 
surface protein. VSGs, which cover the entire parasite surface, are arranged in a tightly 
packed monolayer of homodimers forming a 12-15 nm thick coat which functions as a 
barrier to lytic serum components but allows nutrients such as glucose to reach 
transporters in the membrane (Borst et al., 1998). Each parasite expresses 107 densely 
packed identical VSG molecules on their surface (Cross, 1990, Gerold et al., 1996). 
VSG accounts for about 10% of the total protein and is constitutively synthesized at a 
high rate (about 8% of total protein biosynthesis) (Kang et al., 2002). This abundant 
molecule is very immunogenic, and is, therefore, the target of a very potent immune 
response (Vanhamme et al., 2001).  
The molecular weights of VSGs from different species range from 53 to 63 kDa, 
dependent on the carbohydrate content (Richards, 1984). Tryptic digestion of the C-
terminal portion of the VSG molecule can reduce the MW from 53 to 48 kDa (Rosen et 
al., 1981) 
All VSGs may share a similar backbone structure from which emerge distinct 
epitopes derived from different groups of amino acid side chains. VSGs are all 
homodimers. Each VSG monomer contains a N-terminal signal sequence and a 
hydrophobic C-terminal domain and is covalently attached to a 
glycosylphosphatidylinositol (GPI) membrane anchor (Ferguson et al., 1985, Ferguson 
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& Williams, 1988, Kang et al., 2002). The outer domain, N-terminal sequence, is highly 
variable. By X-ray crystallography, the three-dimensional structures of the N-terminal 
two-thirds of two VSGs have been found to be very similar rod-like shapes despite 
having quite different amino acid sequences (Blum et al., 1993). The VSG molecules 
can be cleaved by the trypanosomal GPI-specific phospholipase C (GPI-PLC). This 
GPI-PLC cleaves the GPI anchor, leaving the dimyristoylglycerol (DMG) compound of 
the GPI anchored in the membrane, and releases the glycosyl-inositol-phosphate (GIP)-
VSG part (also called soluble VSG [sVSG]) (Fox et al., 1986, Magez et al., 1998). 
Figure 1.1 The structure of membrane-VSG (mVSG) of T. brucei (Magez et al., 1998) 
 
 
* The boxed Asp is the C-terminal residue of the VSG 
* 
Protein 
GPI 
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1.1.7.3 Release of sVSG 
The VSG can be detected in the plasma of rats and mice infected with T. brucei 
brucei (Diffley et al., 1980) and in the plasma of mice infected with T. congolense 
(Tabel unpublished) which indicates that trypanosomes shed surface coat material 
during the course of infection. 
VSG coats are stably associated with the parasite plasma membrane but can be 
isolated as the membrane form of VSG (mfVSG) (Bulow et al.) or the freely water-
soluble glycoproteins (sVSG) after cell lysis. mfVSG is readily converted to sVSG 
during cell lysis by the action of an endogenous enzyme (GPI-PLC) (Ferguson, 1999). 
VSG release can be induced by hypotonic lysis (Cardoso De Almeida & Turner, 1983) 
or by different kinds of stress (Bowles & Voorheis, 1982, Rolin et al., 1996).  
GPI-specific phospholipase C (GPI-PLC) is involved in degradation, recycling 
and shedding of VSG (Carrington et al., 1991, Rolin et al., 1996). Each trypanosome 
expresses 30,000 copies of a very active GPI-PLC which, by clipping off the 
dimyristoylglycerol from membrane bound VSG (mfVSG), promotes its shedding in a 
soluble form (sVSG) (Cardoso De Almeida et al., 1999). It was found that trypanosomal 
lysates contain a vast abundance of mainly sVSG produced from mfVSG by action of an 
endogenous GPI-PLC that gains access to surface bound VSG after hypotonic lysis of 
the cell (Fox et al., 1986). GPI-PLC has been implicated in releasing the VSG coat. 
However, its role in GPI hydrolysis is still puzzling because (i) GPI-PLC null mutants 
are fully viable, (ii) cytosolic GPI-PLC is localized away from cell surface VSG, and (iii) 
GPI-PLC null mutants undergo antigenic variation (Cardoso De Almeida et al., 1999). In 
vitro experiments showed that shedding of VSG is mediated by GPI hydrolysis, which 
ultimately accounts for a substantial portion of total release. Surface biotinylation assays 
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indicate that GPI-PLC does gain access to extracellular VSG. All these results indicate 
that GPI-PLC plays a significant role in VSG release (Gruszynski et al., 2003). Recent 
reports also showed that VSG is internalized and recycled exclusively via a specialized 
part of the plasma membrane, the flagellar pocket. The VSG cell-surface pool is turned 
over within 12 minutes. VSG recycling happens through endocytosis in large clathrin-
coated vesicles that bud from the flagellar pocket membrane, and are delivered to 
endosomes and/or lysosome. VSG then returns to the cell surface at the flagellar pocket 
via exocytosis (Engstler et al., 2004). 
In the presence of fresh bovine serum, antibodies against T. congolense can induce 
shedding of soluble VSG and the formation of a soluble covalent complex of VSG and 
bovine complement component C3b (Liu et al., 1993). 
 
1.1.7.4 Effect of VSG on the immune system of the host 
GPI-linked variant surface glycoprotein (VSG) represents 10% of the total protein 
content of trypanosomes (Cross, 1990). Due to the fact that trypanosomes are 
extracellular parasites, and due to the release of vast amounts of soluble VSG into the 
circulation, the immune system of an infected mammalian host is regularly confronted 
with circulating sVSG (Magez et al., 2002). There is evidence that T. congolense 
bloodstream forms evade complement lysis by shedding of immune complexes (Frevert 
& Reinwald, 1990). It has also been demonstrated that VSG of T. brucei cause 
consumption of complement proteins, which may occur via the tremendous amounts of 
immune complexes generated during antibody-mediated clearance of each wave of 
parasitaemia (Musoke & Barbet, 1977). Recent studies have documented the 
immunostimulatory and regulatory activity of protozoan-derived GPI anchors and 
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related structures (Ropert & Gazzinelli, 2000). It is clear that GPI-linked macrophage 
modulation occurs in all protozoan parasite infections (Magez et al., 2002). There is 
growing evidence that soluble VSG that carries the carbohydrate core (GIP-VSG), after 
being released from the parasite surface, is involved in affecting functions of 
macrophages, including the induction of cytokines synthesis, such as TNF-α (Magez et 
al., 2002, Paulnock & Coller, 2001). TNF-α is a key mediator in trypanosomiasis-
associated immunopathology (Hunter et al., 1991, Kang & Schlesinger, 1998, Okomo-
Assoumou et al., 1995, Sileghem et al., 1994b). It has also been reported that GIP-VSG 
inhibits IFN-γ-induced nitric oxide (NO) production by macrophages (Coller et al., 
2003). NO has been shown to be trypanostatic for T. congolense, T. musculi, T. 
gambiense and T. brucei in vitro (Kaushik et al., 1999, Vincendeau & Daulouede, 1991, 
Vincendeau et al., 1992). A complex between VSG and complement component C3b 
named C3b-VSG has been described (Liu et al., 1993). The C3b-VSG complex is 
generated when T. congolense is incubated with bovine serum in the presence of anti-
VSG antibody, and has been suggested to interfere with the phagocytosis of parasites. 
All these results suggest that sVSG released from parasites may have negative effects on 
controlling the infection. 
 
1.2 Immunity 
African trypanosomes are exposed to host immune system from the moment of 
injection. One trypanosome is a package of thousands of invariant antigens surrounded 
by 10 million copies of a single VSG (Vickerman, 1985). The immune system is 
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continually assaulted by massive amounts of the different VSGs and the invariant 
antigens. 
 
1.2.1 Innate immunity 
Innate immunity refers to antigen-nonspecific defense mechanisms that are 
designed to recognize highly conserved structures present in many different 
microorganisms, called pathogen-associated molecular patterns (PAMP) (Aderem & 
Ulevitch, 2000). The innate resistance to African trypanosomiasis, called 
trypanotolerance, is manifested by lower parasitemia and less marked anemia (Dargie et 
al., 1979). The C57BL/6 mouse strain is relatively resistant and the A/J and BALB/c 
strains are susceptible following infection with T. congolense. The speed of control of 
the first wave of parasites positively correlates with the survival period of mice infected 
with T. congolense (Ogunremi & Tabel, 1995). Macrophages of relatively resistant 
C57BL/6 mice produce significantly more NO than macrophages of susceptible BALB/c 
in response to T. congolense (Kaushik et al., 1999).. The differences of resistance 
between C57BL/6 and BALB/c is controlled by five quantitative trait loci (QTL), Tir1, 
Tir2, Tir3a, Tir3b and Tir3c, positioned on mouse chromosomes 17, 5, 1 respectively 
(Iraqi et al., 2000). These loci can account for all of the difference between the parental 
phenotypes but the genes involved in these loci and their mode of mechanism are 
presently unknown. 
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1.2.1.1 Role of complement 
Complement, first described in the 1890s, is a major defense and clearance system 
in the bloodstream. It can be activated via antibody-antigen complex (classical pathway) 
or directly via a foreign particle or organism (alternative pathway). It is an important 
part of the host’s immune system that functions together with the adaptive immune 
response to provide effective mechanisms: killing microorganisms by lysis, facilitating 
the clearance of microorganisms as well as immune complexes by phagocytosis, and 
initiating inflammation (Law & Reid, 1988).  
Complement-mediated lysis of trypanosomes can be observed in vitro (Balber et 
al., 1979) and in vivo (Vickerman & Barry, 1982). Trypanosomal infections in cattle are 
accompanied by a severe depression of hemolytic complement activity (Nielsen et al., 
1978, Tabel et al., 1980) that is less profound in sera from trypanotolerant cattle than 
that from susceptible ones (Authie & Pobel, 1990). Complement depletion in the serum 
could cause further defects in the functioning of the immune response, such as an 
increased susceptibility of trypanosome-infected animals to secondary infections (Maxie 
et al., 1979, Naessens et al., 2000). 
The complement system is composed of about 30 proteins. Of all complement 
components, the component C3 (M.W. = 185kD) is the most prevalent plasma 
glycoprotein (present at a concentration of 1.3 mg/ml). It plays a central role in the 
system since the classical and the alternative pathways merge at the C3 activation step 
(Law & Reid, 1988). Activation of complement component C3 leads to either humoral 
cell killing via assembly of the membrane attack complex, or phagocytosis of the 
opsonized target via the complement receptors on macrophages (Ross & Auger, 2002). 
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C3 is composed of an α chain with molecular weight of 115 kD linked with a 70 kD β 
chain by several disulfide bonds (Morris et al., 1982). 
Figure 1.2 Degradation of complement C3 (Adapted from (Hostetter & Gordon, 1987)) 
 
C3b 
 
C3a 
iC3b 
C3d C3c 
  
17 
C3 can undergo proteolytic cleavage into C3a and C3b in the classical pathway, 
induced by the complex of C4b2a, or be cleaved by serum proteases in the alternative 
pathway. C3b can covalently bind to carbohydrate of foreign cell surfaces. Bound C3b is 
rapidly converted to iC3b by serum factor I and its cofactors (Law & Levine, 1977, Law 
et al., 1979). It has also been reported that iC3b has a much longer half-life than C3b in 
blood (Cain et al., 1987, Ross, 1986). The digestion of iC3b to C3c and C3dg by serum 
proteases is relatively slow. Hence, the majority of bound C3 fragments on target 
surfaces is in the form of iC3b (Law & Reid, 1988). It is well established that the 
presence of iC3b on pathogens enhances their phagocytosis by macrophages and 
polymorphonuclear neutrophils by interacting with complement receptor 3 (CR3) (Cain 
et al., 1987, Preynat-Seauve et al., 2004, Rosenthal et al., 1996, Ross & Medof, 1985). 
Homogenates of T. congolense (Tabel, 1982) or trypanosomes lacking a glycoprotein 
coat can activate the alternative complement pathway (Ferrante & Allison, 1983). It has 
been proposed that during an infection, the binding of IgM antibody to trypanosomes 
results in the deposition of complement component C3 cleavage products, such as C3b 
or iC3b, on the parasites (Devine et al., 1986). The opsonized parasites could thus 
interact with Kupffer cells via specific complement receptors. 
 
1.2.1.2 Macrophages 
1.2.1.2a Biology of macrophages 
Macrophages are widely distributed throughout the body. They can be found in the 
liver (Kuffer cells), lymphoid organs, spleen (macrophage of the marginal zones and red 
pulp macrophages), lungs (alveolar macrophages), central nervous system, serous 
cavities, bone, synovium, skin etc. They can participate in a wide range of physiological 
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and pathological processes (Ross & Auger, 2002). They differentiate from the 
mononuclear phagocyte system. This system comprises bone marrow monoblasts and 
promonocytes and peripheral blood monocytes (Ross & Auger, 2002). Precursors of 
macrophages originate in the bone marrow. The monoblast is the least mature cell of the 
mononuclear phagocyte system, with each giving rise to two promonocytes, the direct 
precursors of monocytes. Each dividing promonocyte gives rise to two monocytes. 
Monocytes remain in the bone marrow for less than 24 h before entering the peripheral 
blood. The peripheral blood monocytes migrate into extravascular tissues to become 
macrophages. The proportion of monocytes migrating to various organs is apparently 
random and corresponds roughly to the size of the organ (Van Furth & Cohn, 1968). The 
liver contains about 80% of the total macrophage population of a mouse (Knolle & 
Gerken, 2000). The tissue macrophages remain in the tissues for several months and do 
not return to the circulation. Macrophages in tissues and body cavities are not a constant 
population of cells, but are being renewed regularly by the influx of monocytes (Ross & 
Auger, 2002). 
Macrophages are generally large, irregularly shaped cells measuring 25-50 µm in 
diameter. They often have an eccentrically placed, round or kidney-shaped nucleus with 
prominent nucleoli and finely dispersed nuclear chromatin. Their cytoplasm contains 
both fine granules and large azurophilic granules and a clearly defined juxtanuclear 
Golgi complex, as well as clear cytoplasmic vacuoles (Goldman, 1989). Macrophages 
represent a major defense against invasion of the host by a wide variety of 
microorganisms, including bacteria, viruses, fungi and protozoa (Ross & Auger, 2002). 
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1.2.1.2b Function of macrophages 
Macrophages count among the most pleiotropic cells of the immune system, 
exhibiting a plethora of biological functions, including phagocytosis, killing of invading 
microorganism and pro- and/or anti-inflammatory activities. They participate in adaptive 
responses through production of a variety of cytokines, expression of costimulatory 
molecules and antigen presentation by their class I and II MHC expression (Noel et al., 
2002). Several functions of murine macrophages are activated during infections by 
African trypanosomes, including phagocytosis, adherence, pinocytosis, oxidative burst, 
prostaglandin release and cytokine secretion (Sileghem et al., 1994a). The elimination of 
trypanosomes by antibodies is thought to be predominantly mediated by opsonization 
and destruction by liver macrophages, rather than by complement-mediated lysis 
(Dempsey & Mansfield, 1983, Jokiranta et al., 1995). Anti-VSG antibody-mediated 
phagocytosis of trypanosomes by macrophages is considered the most important 
mechanism of clearance of trypanosomes from the blood of infected mice (Macaskill et 
al., 1980, Shi et al., 2004). Although there are apparently no differences at the level of 
phagocytosis of trypanosomes, macrophages of susceptible and resistant mice differ in 
their physiological responses after phagocytosis of T. congolense (Kaushik et al., 1999, 
Tabel et al., 2000). Peripheral blood mononuclear cells and monocytes of resistant 
N’Dama cattle were found to produce more nitric oxide (NO) but less IL-10 than those 
of susceptible Boran cattle (Taylor et al., 1998). A similar result was shown in the 
mouse model. Macrophage of resistant C57BL/6 produce significantly higher amounts 
of NO than macrophages from susceptible BALB/c mice in response to T. congolense 
(Kaushik et al., 1999). It was also demonstrated that different antibody classes might 
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activate macrophages via different signaling pathways. Previous studies showed that 
phagocytosis of T. congolense mediated by anti-VSG antibodies of IgG2a isotype in the 
presence of IFN-γ induced two- to nine-fold more NO than phagocytosis mediated by 
IgM antibodies by bone marrow-derived macrophages (BMDM) from both C57BL/6 
and BALB/c mice (Kaushik et al., 1999). It has been well documented that IgG-
mediated phagocytosis occurs via Fc receptors and macrophages activated via Fc 
receptors can produce large amounts of oxidative burst products, such as NO (Bayon et 
al., 1997, Becherel et al., 1995, Dasgupta et al., 2000, Kolb et al., 1995, Vouldoukis et 
al., 2000). The macrophage receptors involved in IgM-mediated phagocytosis of 
trypanosomes are presently not known.  
 
1.2.1.3 Role of nitric oxide 
NO, a free radical gas, works as a nonspecific cytotoxin in the host immune system 
(MacMicking et al., 1997, Moilanen & Vapaatalo, 1995). It is small and lipophilic which 
makes it easy to enter microbes. The prime targets of NO are sulfhydryls and iron which 
are central in the biochemistry of microbes (MacMicking et al., 1997). Nitric oxide (NO) 
produced by activated macrophages in response to various stimuli or pathogens is 
considered to be an important arm of nonspecific immunity (May & Machesky, 2001).  
Sustained production of NO endows macrophages with cytostatic or cytotoxic 
activity against viruses, bacteria, fungi, protozoa, helminthes, and tumor cells (Anggard, 
1994, Snyder & Bredt, 1992). Different stimuli or pathogens can use different signaling 
pathways for NO production. Previous studies showed that Fc receptors (Bayon et al., 
1997, Becherel et al., 1995), Toll-like receptors (Mizel et al., 2003) and mannose 
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receptors (Karaca et al., 1995) are involved in inducing NO synthesis. The high-output 
NO pathway has probably evolved to protect the host from infection (MacMicking et al., 
1997). NO has been shown to be trypanostatic for T. congolense, T. musculi, T. 
gambiense and T. brucei in vitro (Kaushik et al., 1999, Vincendeau & Daulouede, 1991, 
Vincendeau et al., 1992). Peritoneal macrophages and bone marrow-derived 
macrophages of resistant C57BL/6 mice produce significantly higher NO than 
macrophages of susceptible BALB/c in response to T. congolense (Kaushik et al., 1999). 
NO has also been reported to be partially responsible for macrophage-mediated splenic 
immunosuppression observed in T. brucei-infected highly susceptible mice (Mabbott et 
al., 1995), but not in T. congolense-infected mice (Uzonna et al., 1998c). The role of NO 
in relatively resistant mice remains to be determined. Recent reports show that NO 
contributes to the immunosuppressive activity only during the early stages of murine T. 
brucei infection (Beschin et al., 1998). NO was not upregulated during T. congolense 
infection of cattle and was not found responsible for reduction in T cell proliferation 
(Taylor, 1998, Taylor et al., 1996). Therefore, the role of NO in trypanosome infection 
still needs to be determined, but it may at least partially account for differences in 
resistance to T. congolense infection in mice. 
 
1.2.2 Adaptive  immunity 
Adaptive (acquired) immunity, including two major categories (humoral immunity 
and cell-mediated immunity), refers to antigen-specific defense mechanisms.  
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1.2.2.1 Humoral immune responses 
Humoral immunity is mediated by antibody molecules in response to an antigen 
and they are produced by B-lymphocytes. The VSG surface epitope-specific B-cell 
responses in trypanosome-infected mice represent composite T-cell-independent and T-
cell-dependent processes (Reinitz & Mansfield, 1990). The T cell-independent, VSG-
specific, B-cell responses are associated with temporary immunity to the trypanosome 
variant antigenic types (VATs) arising during chronic infection (Campbell & Phillips, 
1976, Pinder et al., 1986, Reinitz & Mansfield, 1990). The relative contribution of T-
cell-independent and T-cell-dependent processes to the total VSG-specific antibody 
produced during infection is variable, which may reflect differences in the primary 
structure or display of VSG molecules on the trypanosome membrane or may represent 
active parasite interference with some epitope-specific B cell responses (Reinitz & 
Mansfield, 1990).  
The B-cell specific responses to the trypanosomal variant surface glycoprotein 
(VSG) result in the elimination of organisms expressing the target surface antigen, and 
thereby control the parasitemia. Parasites are rapidly eliminated from the circulation in 
the presence of specific antibody (Mansfield, 1990, Shi et al., 2004). The mice that are 
highly susceptible to trypanosomiasis produce little or no detectable antibody against the 
VSG during an infection (Black et al., 1983, Morrison & Murray, 1985) in spite of their 
B lymphocytes being extensively activated while resistant mice exhibit superior 
antibody synthesis and secretion (Black et al., 1986, Levine & Mansfield, 1984, Newson 
et al., 1990). The primary immune response to the VSG reaches a maximum within 7-14 
days after challenge (Roelants & Pinder, 1984) and consists of both IgM and IgG classes 
of antibody. IgM and IgG antibodies against VSG appear equally effective in mediating 
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phagocytosis in vitro. However, IgM has been shown to be the only class detectable 
during the initial parasitemic wave (Dempsey & Mansfield, 1983). It also has been 
shown that the highly immunogenic VSG can induce high levels of IgM antibodies in 
infected cattle and mice (Radwanska et al., 2000). The enormous IgM antibody 
production is not accompanied by a concomitant increase in IgG antibody in susceptible 
BALB/c mice (Uzonna et al., 1999). Whether the type of antibody response is the cause 
for resistance to the infection as measured by survival time is still not clear, but 
differences in the levels of antibody production and in the class of antibody produced 
have been found between relatively resistant and susceptible mice. 
 
1.2.2.2 Role of antibody 
The production of antibody to the various predominant VSGs expressed provide 
protective immunity in infected animals (Naessens et al., 2000). VSG-specific antibodies 
mediate complement-mediated lysis (Crowe et al., 1984, Flemmings & Diggs, 1978), 
agglutination (Russo et al., 1994), immobilization (Wei et al., 1990) and increased 
uptake by macrophages (Ngaira et al., 1983, Shi et al., 2004) of trypanosomes. It is 
established that the clearance of the predominant variant antigenic type of parasite is an 
immune-mediated mechanism and requires VSG-specific antibodies (Pinder et al., 1986). 
Opsonization with VSG-specific antibodies results in rapid uptake of the parasites by 
macrophage (Radwanska et al., 2000, Shi et al., 2004, Uzonna et al., 1999). In the 
absence of antibodies, bloodstream trypanosomes are protected against phagocytosis by 
the surface coat (Mosser & Roberts, 1982). Antibodies to non-variant antigens may not 
be involved in killing or clearance of trypanosomes. They, however, may neutralize the 
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pathogenic or toxic effects of certain trypanosomal molecules, and therefore, may 
prevent anemia after repeated heterologous infections (Paling et al., 1991). 
It was found that, upon infection, highly susceptible BALB/c mice made IgM 
antibodies to common trypanosomal epitopes earlier than relatively resistant C57BL/6 
mice. In contrast to C57BL/6 mice, BALB/c mice failed to switch to produce IgG3 and 
IgG2a antibodies (Uzonna et al., 1999). When infected BALB/c mice were cured by 
treatment with Berenil, they did produce antibodies of IgG3 and IgG2a isotypes reacting 
with common trypanosome epitopes. Mice that underwent self-cure after T. congolense 
infection were found to have the highest serum levels of IgG3 and IgG2a antibodies to 
common antigens of T. congolense (Uzonna et al., unpublished). It has been observed 
that monoclonal IgG2a anti-VSG plus T. congolense, when added to macrophage 
cultures, induced 2 to 9-fold more NO in the macrophages than those trypanosomes 
opsonised with monoclonal IgM anti-VSG antibody (Kaushik et al., 1999). IgM was 
more efficient than IgG in agglutination, and complement-mediated lysis  of T. brucei 
(Seed, 1977). In vitro experiments showed that IgM and IgG anti-VSG have equivalent 
effects in regard to phagocytosis, but they have different effects on macrophage 
activation (Kaushik et al., 1999). 
 
1.2.2.3 Cellular immune responses 
After trypanosome infection, T-lymphocyte proliferation occurs but is depressed 
as infection progresses (Mayor-Withey et al., 1978). The T cell responses against 
trypanosomes are not well characterized. T-cell requirements were examined by analysis 
of gamma globulin preparations derived from trypanosome-infected BALB/c nude 
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(nu/nu) and thymus-intact (nu/+) mice. Analysis of VSG-specific antibody in infected 
mice demonstrated that in the absence of T cells there was a significant B-cell response 
to exposed VSG epitopes; however, in the presence of T cells these surface epitope-
specific responses were greatly enhanced. Immunization with VSG in the absence of 
infection elicited only T-cell-dependent responses (Reinitz & Mansfield, 1990). The first 
direct evidence of stimulation of VSG-specific Th cells during trypanosome infection 
was obtained by Schleifer (Schleifer & Mansfield, 1993). CD4+ Th cells specific for 
VSG were found predominantly in the peritoneal cavity of infected resistant mice, but 
TH cell responses in infected susceptible mice were not studied (Schleifer & Mansfield, 
1993). The immunity is not transferred with T cell-enriched spleen subpopulations. It 
was shown that treatment of spleen cells with anti-thymic cell and complement did not 
affect their ability to transfer immunity (Takayanagi & Nakatake, 1975). Mice deprived 
of B cells, but not T cells, are unable to mount an effective response (Campbell et al., 
1977). Reduced T and B cell responsiveness has been attributed to T-cell-mediated 
immunosuppression (Eardley & Jayawardena, 1977, Jayawardena et al., 1978, Pearson 
et al., 1978, Pearson et al., 1979). Recently reports showed that there are suppressor 
(Uzonna et al., 1998c) and pathogenic T cell populations (Shi et al., 2003) in T. 
congolense-infected mice. These cells are the major producers of IFN-γ, which 
contributes to the suppression of splenocyte proliferative responses to Con A in the mice 
(Uzonna et al., 1998a, Uzonna et al., 1998b). These cells are also involved in the in vitro 
suppression of B cell responses to a T cell-dependent Ag as well as in the suppression of 
T cell proliferative responses to Con A. It appears that the IFN-γ producing T cells that 
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show suppressor activity and disease-enhancing effects are predominantly CD4+ (Shi et 
al., 2003, Uzonna et al., 1998c) and MHC-II-restricted (Shi, unpublished). 
 
1.2.2.4 Role of cytokines 
IFN-γ is an important cytokine in the pathogenesis of trypanosomiasis. Enhanced 
induction and secretion of IFN-γ during T. congolense infections mediates mortality in 
highly susceptible BALB/c mice (Shi et al., 2003, Uzonna et al., 1998a). Treatments of 
infected susceptible BALB/c mice with anti-IFN-γ antibody significantly reduces the 
parasitemia of these highly susceptible mice and increases their life-span (Shi et al., 
2003, Uzonna et al., 1998a). T. brucei infected mice with disrupted IFN-γ genes have 
been reported to have decreased parasitemia and increased survival times (Bakhiet et al., 
1996). The opposite results have also been observed (Hertz et al., 1998, Namangala et al., 
2001). IFN-γ has been claimed to act as a growth factor for T. brucei (Olsson et al., 
1991). However, IFN-γ was not found to have growth stimulatory effects on T. 
congolense (Kaushik et al., 1997). IFN-γ can play a detrimental or beneficial role in 
animals infected with African trypanosomes. The role of IFN-γ may depend on a number 
of factors, such as the trypanosome species, virulence of the infecting strains, as well as 
the genetic status of the trypanosome-bearing host. 
Tumor necrosis factor (TNF-α) is an inflammatory cytokine which exerts a wide 
range of biological activities including the induction of cellular proliferation and 
differentiation, apoptosis, cytotoxicity, inflammation and immunomodulation (Aggarwal 
& Natarajan, 1996). Induction of TNF-α and its role in immunopathology has been 
extensively documented in African trypanosomiasis (Hunter et al., 1991, Kang & 
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Schlesinger, 1998, Okomo-Assoumou et al., 1995, Sileghem et al., 1994b). Enhanced 
expression of TNF-α in the brains of Trypanosoma brucei-infected mice has been 
reported (Hunter et al., 1991).  The continual release of TNF-α (cachectin) from 
activated macrophages are the hallmark of chronic wasting disease associated with 
trypanosomiasis (Beutler & Cerami, 1988). Associations have also been found between 
TNF-α production by monocytes and the severity of disease-associated anemia in 
trypanosome-infected cattle (Sileghem et al., 1994b), the neuropathological symptoms in 
human sleeping sickness patients (Okomo-Assoumou et al., 1995) and trypansosome-
elicited immunosuppression and overall morbidity (Magez et al., 1999). There are no 
reports of TNF-α playing a role in resistance to T. congolense infections in mice (Magez 
et al., 1999).  
IL-10 is known to suppress expression of other cytokines and regulatory 
molecules, such as NO (Taylor et al., 1998). T. congolense-infected cattle have elevated 
levels of mRNA encoding IL-10 in cells from blood, lymph node and spleen, suggesting 
that IL-10 might be related to the apparent failure of bovine monocytes to produce 
inflammatory molecules (Taylor et al., 1998). The increase in IL-10 is found in both 
tolerant N’Dama and susceptible Boran cattle and hence may not be associated with 
trypanotolerance or susceptibility (Naessens et al., 2000). Following infection with T. 
congolense, the plasma of the highly susceptible BALB/c mice contains significantly 
higher levels of IL-10 than that of relatively resistant C57BL/c mice. Anti-IL-10 
antibody treatment significantly reduced the parasitemia and moderately increased the 
survival period of highly susceptible BALB/c mice (Uzonna et al., 1998b), which 
suggests that IL-10 is a disease-enhancing cytokine during T. congolense infection in 
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mice. On the other hand, IL-10 is absolutely required to counteract the detrimental 
effects of IFN-γ in T. congolense-infected mice (Shi et al., 2003). 
 
1.3 Receptors on macrophages involved in phagocytosis 
Various receptors have been reported on the surface of macrophages. They control 
multiple of activities of macrophages, such as growth, differentiation, activation, 
endocytosis, recognition, migration and secretion (Ross & Auger, 2002). 
Phagocytosis, a phrase first coined by Metchnikoff (cited by (Ross & Auger, 
2002)), is defined as the cellular engulfment of large particles, usually those over 0.5 µm 
in diameter (May & Machesky, 2001). Phagocytosis of pathogens by macrophages can 
initiate innate immune responses, which in turn orchestrates the adaptive response. In 
order to discriminate between infectious agents and self, macrophages have evolved a 
restricted number of phagocytosis receptors (Aderem & Underhill, 1999). 
 
1.3.1 Fc receptors 
The receptors for the Fc region of the IgG molecule are one kind of receptor that 
was firstly identified on the macrophages (Berken & Benacerraf, 1966). The attachment 
of the Fc portions of immunoglobulin (Igs) to the surface of the macrophage via Fc 
receptors triggers various functions, such as endocytosis, transmembrane signal 
generation, phagocytosis, and secretion of potent mediators (production of superoxide, 
cytokines etc.) (Roitt, 1994, Ross & Auger, 2002). Antibodies act as opsonins that 
render the particle they coat more susceptible to engulfment by phagocytic cells. Most of 
the understanding of the signaling pathways leading to phagocytosis in macrophages 
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comes from studies involving the Fc receptor (Ravetch, 1997, Ravetch & Clynes, 1998, 
Unkeless et al., 1995). 
There are different Fc receptors on macrophages that can recognize Fc portions of 
IgG (FcγRs) and IgA (FcαR) (Ross & Auger, 2002). A range of FcγRs exist (Sanchez-
Mejorada & Rosales, 1998). FcγRI (Indik et al., 1994), FcγRIIA (Tuijnman et al., 1992) 
and FcγRIIIA (Park et al., 1993) can all support phagocytosis in human macrophages. 
FcγRI (CD64) has high affinity for monomeric IgG, while FcγRII (CD32) and FcγRIII 
(CD16) have only low affinity for monomeric IgG, but can effectively bind immune 
complexes by multiple receptor-ligand interactions (Unkeless et al., 1988). There is no 
mouse counterpart of the human FcγRIIA (Aderem & Underhill, 1999). Murine and 
human macrophages express FcγRIIB (an isoform of FcγRIIA), an inhibitory receptor 
that negatively regulates phagocytosis (Hunter et al., 1998, Odin et al., 1991, Ravetch, 
1994). FcγRIIIB is able to initiate calcium signaling and actin polymerization, but its 
role in phagocytosis remains unclear (Chuang et al., 2000, Kimberly et al., 1990, Salmon 
et al., 1991).  
FcγRI and FcγRIIA are expressed on neutrophils and macrophages, which are 
both professional phagocytes. FcγRIIIA is restricted to macrophages, and FcγRIIIB is 
present only on neutrophils (Sanchez-Mejorada & Rosales, 1998). FcγR-mediated 
ingestion occurs by a zipper-like process, in which FcγRs in the macrophage plasma 
membrane interact sequentially with IgG molecules distributed over the surface of the 
ingested particle (Silverstein, 1995). FcγR-induced phagocytosis is tightly coupled to the 
production and secretion of proinflammatory molecules such as reactive oxygen 
intermediates and proinflammatory cytokines (Aderem et al., 1985, Wright et al., 1983). 
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1.3.2 Complement receptors 
The receptors for the cleavage products of the third component of complement 
(C3) are other receptors on macrophages (Lay & Nussenzweig, 1968). Activation of the 
complement component C3 can lead either to humoral cell killing via assembly of the 
membrane attack complex or to phagocytosis of the opsonized target via the 
complement receptor (Ross & Auger, 2002). Complement-receptor-mediated 
phagocytosis is morphologically distinct from that mediated by FcRs, although both 
processes require actin polymerization. Complement-opsonised particles ‘sink’ into the 
phagocyte; there is minimal membrane disturbance, and internalization does not usually 
lead to an oxidative burst (May & Machesky, 2001). 
Complement proteins opsonize particles for phagocytosis by the C3b or iC3b 
receptors (CRs) on macrophages. Receptors expressed on macrophages that participate 
in phagocytosis of complement-opsonized particles, include CR1, CR3 and CR4 (Carroll, 
1998, Sengelov, 1995). CR1 is a single chain transmembrane protein consisting of a 
large extracellular lectin-like complement-binding domain and a short 43 amino acid 
cytosolic domain. CR1 binds C3b and primarily functions in particle adherence rather 
than internalization (Brown, 1991). CR3 and CR4 are integrin family members made up 
of heterodimers of different α chains (CD11b for CR3 and CD11c for CR4) 
noncovalently associated with a shared β chain (CD18). CR3 molecules bind 
specifically to iC3b and are responsible for particle internalization. The ligand for CR4 
is still unclear but may also be iC3b (Sengelov, 1995).  
CR3 has been the most widely studied. It is predominantly expressed on 
neutrophils, monocytes, macrophages, and natural killer cells (Arnaout, 1990).  Distinct 
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functional domains have been identified in the extracellular portion of the CD11b 
subunit of CR3 (Balsam et al., 1998, Dana et al., 1986, Diamond et al., 1993, Lu et al., 
1998, Thornton et al., 1996): the I- or A- domain is essential for binding and 
phagocytosis of iC3b-coated particles. CR3 is capable of binding to several ligands 
through different recognition sites. Binding to iC3b leads to particle phagocytosis, but 
the receptor can also mediate non-opsonic phagocytosis of particles by binding to 
molecules such as β-glucan (Thornton et al., 1996). The phagocytosis of iC3b-opsonised 
particles by CR3 proceeds efficiently only if the phagocyte is first activated, for example, 
by inflammatory cytokines or by attachment to the extracellular matrix (Brown, 1986, 
Pommier et al., 1983). Notably, CR3 has been shown to associate with FcγRIII (Zhou et 
al., 1993), and the two phagocytic receptors cooperate in regulating the respiratory burst 
(Zhou & Brown, 1994). 
 
1.3.3 Other receptors 
1.3.3.1 Mannose receptors 
The mannose receptor (MR) on macrophages recognizes mannose and fucose on 
the surface of pathogens and mediates phagocytosis of the organisms (Stahl & 
Ezekowitz, 1998). MR is a phagocytic receptor with broad pathogen specificity because 
of its high affinity for branched mannose and fucose oligosaccharides (Aderem & 
Underhill, 1999). It is perhaps the best characterized of the macrophage lectins involved 
in host defense. MR is a 175-KDa single chain receptor with a short cytoplasmic tail and 
an extracellular domain including 8 lectin-like carbohydrate-binding domains.  The 
cytoplasmic tail is crucial to both the endocytic and phagocytic functions of the receptor, 
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but little is known about the signals that lead to phagocytosis (Ezekowitz et al., 1990, 
Stahl & Ezekowitz, 1998).  
The expression of the MR is regulated (Rouleux-Bonnin et al., 1994, Rouleux-
Bonnin et al., 1995). Although previously it was thought that it was restricted to tissue 
macrophages, it is clear that the MR is expressed on immature dendritic cells (DCs) 
(Reis e Sousa et al., 1993, Sallusto et al., 1995), subsets of  endothelial cells 
(Bijsterbosch et al., 1996, Magnusson & Berg, 1993), tracheal smooth muscle cells (Lew 
& Rattazzi, 1991, Lew et al., 1994), retinal pigment epithelium (Lutz et al., 1995, 
Shepherd et al., 1991), kidney mesangial cells (Liu et al., 1996), and Kaposi sarcoma 
cells (Uccini et al., 1997). MR expression is modulated by immunoglobulin receptors 
(Schreiber et al., 1991a, Schreiber et al., 1991b), pathogens and their products 
(Lefkowitz et al., 1997, Shepherd et al., 1997) and other factors (Schreiber et al., 1990). 
The mannose receptor recognizes the patterns of carbohydrates that decorate the 
surfaces and cell walls of infectious agents, and has been implicated in binding and 
phagocytosis of a wide range of microorganisms, such as Gram-negative and Gram-
positive bacteria, yeast, parasites and mycobacteria (Linehan et al., 2000). An important 
role of MR in host defense is suggested by the fact that MR-mediated phagocytosis is 
modulated by the proinflammatory cytokine IFN-γ (Marodi et al., 1993). During IFN-γ-
mediated macrophage activation, receptor expression is downregulated as a result of 
reduction in the MR mRNA transcripts. However, IFN-γ-treated macrophages exhibit an 
increased capacity to kill the yeast Candida albicans in a MR-dependent manner 
(Marodi et al., 1993). It appears that the MRs that remain accessible after IFN-
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γ treatment significantly enhance MR-dependent phagocytosis (Marodi et al., 1993, 
Stahl & Ezekowitz, 1998). 
 
1.3.3.2 Scavenger receptors 
Scavenger receptors (SRs) are a family of cell surface glycoproteins able to bind 
modified low density lipoprotein (mLDLs) (Krieger, 1997). A number of different 
scavenger receptors (SR-A, SR-B SR-C, SR-D, SR-E, SR-F, SR-PSOX, FEEL-1 AND 
FEEL-2) have now been identified, not only in macrophages but also other cells. The 
growing scavenger receptor family also currently includes cell surface receptor (SR-BI) 
whose main ligand is high density lipoprotein (HDL) (Horiuchi et al., 2003). SRs can 
alter cell morphology and their expression is affected by various cytokines (Peiser et al., 
2002). 
SRs have several functions, including endocytosis, antigen presentation, adhesion 
and phagocytosis and pattern recognition. They play an important role in uptake and 
clearance of effete components, such as modified host molecules and apoptotic cells. 
SRs can also bind and internalize microorganisms and their products, such as Gram-
positive bacteria, Gram-negative bacteria, intracellular bacteria and CpG DNA (Peiser et 
al., 2002). SR-A-mediated phagocytosis of apoptotic cells (Platt et al., 1996), and Gram-
negative and Gram-positive bacteria has been demonstrated (Thomas et al., 2000). The 
cell biology of SR-A-mediated phagocytosis following receptor ligation is not 
understood and the response of macrophages following SR-A-mediated ingestion of 
both apoptotic cells and microorganisms has not been investigated. Macrophage receptor 
with collagenous structure (MARCO) can also bind Gram-negative and Gram-positive 
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bacteria. Although no data directly support that it is involved in phagocytosis, MARCO 
is expressed on macrophages of the marginal zone in the spleen, a population which is 
highly phagocytic and efficient at capturing antigens from the blood stream (Peiser & 
Gordon, 2001).  
 
1.3.3.3 Toll-like receptors 
Toll-like receptors (TLRs) have been identified as ancient receptors that confer 
specificity to the host’s innate immune system allowing the recognition of ‘pathogen-
associated molecular patterns (PAMPs) (Aderem & Ulevitch, 2000, Kopp & Medzhitov, 
1999). In mammals there are at least 10 members of the Toll-like receptor (TLR) family 
(TLR1-TLR10) that recognize specific components conserved among microorganisms 
(Takeda et al., 2003). TLR family members are characterized structurally by the 
presence of a leucine-rich repeat (LRR) domain in their extracellular domain and a TIR 
(Toll/IL-1) domain in their intracellular domain (Takeda et al., 2003). TLRs are required 
for detection of a broad range of microbial products including lipopolysaccharide, 
peptidoglycan, and bacterial lipopeptides (Aderem & Ulevitch, 2000, Akira et al., 2001), 
and several TLR family members are actively recruited to phagosomes during microbe 
internalization (Ozinsky et al., 2000, Underhill et al., 1999a). Expression of TLRs is 
modulated by a variety of factors such as microbial invasion, microbial components, and 
cytokines (Takeda et al., 2003). 
TLR2 recognizes components from a variety of microorganisms, including 
lipoproteins from pathogens such as Gram-negative bacteria, Mycoplasma and 
spirochetes (Aliprantis et al., 2000, Brightbill et al., 1999, Hirschfeld et al., 1999, Lien et 
al., 1999), peptidoglycan and lipoteichoic acid from Gram-positive bacteria (Lehner et 
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al., 2001), lipoarabinomannan from mycobacteria (Underhill et al., 1999b), a phenol-
soluble modulin from Staphylococcus epidermidis (Hajjar et al., 2001), zymosan from 
fungi (Underhill et al., 1999a), glycolipids from Treponema maltophilum (Opitz et al., 
2001), porins that constitute the outer membrane of Neisseria (Massari et al., 2002), and 
also glycoinositolphospholipids from Trypanosoma cruzi (Campos et al., 2001). The 
GPI anchors purified from T. cruzi, which contain a long glycan core and unsaturated 
fatty acids, triggered TLR-2 at subnanomolar concentrations (Campos et al., 2001). By 
using TLR-2 knock out mice, it was found that TLR-2 expression appears to be essential 
for induction of IL-12, TNF-α and NO by GPI anchors, which means that GPIs are 
potent activators of TLR-2 from both mouse and human origin. The activation of TLR-2 
may initiate the host’s innate defense mechanisms and inflammatory response during 
protozoan infection. TLR6 functionally cooperates with TLR2 to recognize microbial 
lipopeptides (Takeuchi et al., 2001). TLR2 and TLR6 co-immunoprecipitate, suggesting 
that they physically interact in the cell (Ozinsky et al., 2000). 
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2. HYPOTHESES AND OBJECTIVES 
2.1 Hypotheses 
1. CR3 (Mac-1, CD11b/18) is involved in IgM anti-VSG mediated 
phagocytosis of trypanosomes  
2. Monoclonal IgM anti-VSG induces shedding of soluble VSG from T. 
congolense  
 
2.2 Objectives 
1. Test whether CR3 (Mac-1; CD11b/18) is involved in IgM anti-VSG-
mediated phagocytosis of T. congolense by macrophages  
2. Test the effects of anti-VSG antibody and complement on the release of 
soluble VSG from T. congolense 
 
 
 
  
37 
NOTE:  
Chapter 3 was submitted on Feb, 16, 2005 to Journal of Infection and Immunity 
as: Wanling Pan, Oladele Ogunremi, Guojian Wei, Meiqing Shi, and Henry Tabel, CR3 
(CD11b/CD18), the major macrophage receptor for IgM antibody-mediated 
phagocytosis of Trypanosoma congolense: diverse effect on subsequent synthesis of 
TNF-α and nitric oxide. 
The work was all done by Wanling Pan, except the data for Figure 3.1 and Figure 
3.7 that were produced by Dele Ogunremi. 
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3. CR3 (CD11b/CD18), THE MAJOR MACROPHAGE RECEPTOR FOR 
IGM ANTIBODY-MEDIATED PHAGOCYTOSIS OF TRYPANOSOMA 
CONGOLENSE: DIVERSE EFFECT ON SUBSEQUENT SYNTHESIS OF 
TNF-α AND NITRIC OXIDE 
 
3.1 Abstract 
Production of antibodies to the variant surface glycoprotein (VSG) of African 
trypanosomes is one of the major immune responses leading to control of parasitemia. 
IgM antibodies are the first and predominant class of anti-trypanosomal antibodies in 
infected animals. IgM antibodies to VSG (IgM anti-VSG) mediate phagocytosis of 
Trypanosoma congolense. The receptor(s) on macrophages that recognizes IgM anti-
VSG-coated African trypanosomes is unknown. We showed that murine complement C3 
fragments were deposited onto T. congolense when the trypanosomes were incubated 
with IgM anti-VSG and fresh mouse serum. We assessed whether complement receptor 
CR3 (CD11b/CD18) might be involved in mediating phagocytosis of T. congolense. We 
found that, in the presence of fresh mouse serum, there was significantly and markedly 
less phagocytosis of IgM-opsonized T. congolense by CD11b-deficient macrophages 
compared to phagocytosis by normal macrophages (78% fewer T. congolense were 
ingested per macrophage). There was significantly less TNF-α  (38% less), but 
significantly more nitric oxide (NO) (63% more) released by CD11b-deficient 
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macrophages that had engulfed trypanosomes than by equally treated normal 
macrophages. We conclude that CR3 is a major, but not the only, receptor involved in 
IgM anti-VSG-mediated phagocytosis of T. congolense by macrophages. We further 
conclude that signaling via CR3, associated with IgM anti-VSG-mediated phagocytosis 
of T. congolense, either directly or indirectly enhance synthesis of disease-producing 
TNF-α, and inhibit synthesis of parasite-controlling NO. 
 
3.2 Introduction 
Trypanosoma congolense is a protozoan pathogen of cattle and other livestock. 
The parasite, like other members of the genus Trypanosoma, is responsible for the 
disease known as African trypanosomiasis (Mulligan & Potts, 1970). In the mammalian 
host, the whole parasite is coated with a glycoprotein coat of a single molecular species, 
called variant surface glycoprotein (VSG). African trypanosomes express about 107 
densely packed identical VSG molecules on their surface (Cross, 1990). VSG is the 
major surface antigen and serves as a protective coat for the parasites.  
The VSG is highly immunogenic and induces high levels of IgM antibodies in 
humans and animals infected with T. brucei or T. congolense (Binz et al., 1968, 
Clarkson, 1976, Greenwood & Whittle, 1973, Hudson et al., 1976, Luckins, 1976). IgM 
antibodies are the first and predominant class of anti-trypanosomal antibodies in mice 
and can be produced independently of T cell help (Campbell et al., 1978, Pinder et al., 
1986). Antibodies to the VSG of T. congolense mediate control of parasitemia. In the 
absence of antibodies, bloodstream trypanosomes are protected against phagocytosis by 
the surface coat (Dempsey & Mansfield, 1983, Macaskill et al., 1980, Pinder et al., 
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1986). Opsonization with VSG-specific antibodies results in rapid uptake of the 
parasites by Kupffer cells in the liver (Dempsey & Mansfield, 1983, Macaskill et al., 
1980, Shi et al., 2004). IgM anti-VSG-mediated phagocytosis of T. congolense by 
macrophages has been shown by experiments carried out in vitro and in vivo (Kaushik et 
al., 1999, Shi et al., 2004). The macrophage receptor(s) recognizing IgM antibody-
coated trypanosomes and enabling their phagocytosis is unknown. 
IgM antibodies, after binding to antigen, are most efficient in activating the 
complement cascade (Law & Reid, 1988). It has been reported that phagocytosis of T. 
congolense (Shakibaei & Frevert, 1992) or T. brucei (Greenblatt et al., 1983, Macaskill 
et al., 1980) is optimal in the presence of functional complement. In African 
trypanosomiasis of humans, livestock and mice, the complement system is greatly 
activated, especially via the alternative pathway (Flemmings & Diggs, 1978, Malu & 
Tabel, 1986, Otesile et al., 1991). 
The complement system is composed of some 30 proteins. Of all complement 
components, C3 is present at the highest concentration in plasma (~1.2 mg/ml) and holds 
a key position in the complement system (Law & Reid, 1988). Complement activation 
by immune complexes or antibody-opsonized cells results in the covalent attachment of 
C3b molecules to surface hydroxyl or amino groups. The plasma protease factor I, in 
synergy with factor H, rapidly cleaves surface-bound C3b into iC3b (May & Machesky, 
2001). It is well established that the presence of iC3b on pathogens enhances their 
phagocytosis by macrophages and polymorphonuclear neutrophils by interacting with 
CR3 (Cain et al., 1987, Preynat-Seauve et al., 2004, Rosenthal et al., 1996, Ross & 
Medof, 1985). Therefore, it is conceivable that phagocytosis induced by IgM anti-VSG 
is mediated via CR3 on macrophages. 
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TNF-α is an inflammatory cytokine which exerts a wide range of biological 
activities including cellular proliferation and differentiation, apoptosis, cytotoxicity, 
inflammation and immunomodulation (Aggarwal & Natarajan, 1996). In African 
trypanosomiasis, TNF-α is a disease-enhancing cytokine produced by activated 
macrophages (Magez et al., 1999). Activated macrophages also secrete nitric oxide (NO) 
that is cytotoxic to T. brucei (Duleu et al., 2004, Gobert et al., 1998, Vincendeau & 
Daulouede, 1991) and T. congolense (Kaushik et al., 1999). 
The purpose of this study was to define whether CR3 (CD11b/CD18) is one of 
the receptors involved in IgM-mediated phagocytosis of T. congolense by macrophages 
and to investigate potential signaling via CR3.  
We exposed normal and CD11b-deficient murine peritoneal macrophages to T. 
congolense together with IgM anti-VSG antibody and fresh mouse serum and compared 
the degree of phagocytosis by immunocytochemistry. We show that, in the presence of 
fresh mouse serum, there is significantly less phagocytosis of IgM-opsonized T. 
congolense by CD11b-deficient macrophages compared to that by normal macrophages. 
In addition, our results show that there is significantly less TNF-α, but significantly 
more NO, released by CD11b-deficient macrophages that have engulfed trypanosomes 
than by equally treated normal macrophages. Together these results suggest that CR3 is 
the major, but not the only, receptor on macrophages involved in IgM anti-VSG-
mediated phagocytosis of T. congolense. The biological significance of the subsequently 
enhanced synthesis of TNF-α and decreased NO production by CD11b-deficient 
macrophages will be discussed.  
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We also investigated a potential correlation between deposition of C3b onto 
target cells, via activation of the alternative complement pathway, and the survival of 
mice infected with T. congolense. 
The alternative pathway of complement activation in susceptible BALB/c differs 
from that of relatively resistant C57BL/6 mice (Ogunremi et al., 1993). We asked the 
question whether the differences in the alternative pathways of complement activation 
might correlate with resistance to T. congolense infections. By cross-breeding BALB/c 
and C57BL/6 mice, we generated a population of F2 offspring. We then investigated 
whether the deposition of plasma C3b/iC3b (CR3 ligand), via activation of the 
alternative complement pathway, onto zymosan correlated with the survival of these 
mice infected with T. congolense. 
 
3.3 Materials and Methods: 
Parasites 
T. congolense, Trans Mara strain, variant antigenic type (VAT) TC13 was used 
in this study. The origin of this parasite strain has been previously described (Tabel, 
1982). Frozen stabilates of parasites were used for infecting CD1 mice 
immunosuppressed with cyclophosphamide, and passages were made every third day as 
described previously (Tabel, 1982). The parasites purified from the blood of infected 
CD1 mice by DEAE-cellulose chromatography (Lanham & Godfrey, 1970) were used 
for co-culture with macrophages. 
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Antibodies 
The rat hybridoma MCAP497 (IgG2a isotype) (specific for mouse macrophage 
antigen F4/80) was purchased from the American Type Culture Collection (ATCC, 
Manassas, Virginia, U.S.A). Biotin-conjugated goat anti-rat IgG2a was purchased from 
Cedarlane (Hornby, Ontario, Canada). Biotin-conjugated goat anti-rabbit IgG was 
purchased from Vector Laboratories (Burlingame, CA). Goat anti-rabbit IgG conjugated 
with Alexa Fluor 546 and streptavidin Alexa Fluor 488 were obtained from Molecular 
Probes (Eugene, Oregon, USA). Recombinant TNF-α and antibodies against TNF-α 
were purchased from BD Biosciences PharMingen (San Diego, CA). Recombinant IFN-
γ was purchased from R&D Systems Inc. (Minneapolis, USA). Production of 
monoclonal anti-mouse complement component C3 11H9 has been previously described 
(Kremmer et al., 1990). Peroxidase-labelled goat anti-mouse C3 was obtained from 
Cappel Laboratories (Cochranville, Pa., USA). The production of the polyclonal rabbit 
anti-T. congolense (Shi et al., 2003), and of monoclonal antibodies (mAb) 6C1 and 5A8 
(IgM) specific for the VSG of VAT TC13 has been described (Wei et al., 1990). 
 
Mice 
Eight to 10 week-old, female, CD11b-deficient mice were obtained from Jackson 
Laboratories (genetic background: C57BL/6; strain name: B6.129S4-Itgamtm1Myd/J; 
stock number: 003991).  Eight to 10 week-old C57BL/6 and BALB/c mice of both sexes 
and 5 to 8 week-old, female, Swiss white mice (CD1) were purchased from the Animal 
Resource Center of the University of Saskatchewan (Saskatoon, Canada). The mice were 
kept in polycarbonate cages on sawdust, and allowed free access to food and water 
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throughout the experiments, according to the recommendations of the Canadian Council 
of Animal Care. 
 
Breeding of mice 
BALB/c and C57BL/6 mice were cross-bred to produce F2 progeny as described 
(Ogunremi & Tabel, 1995). Female offspring were identified at weaning and were bled 
for plasma at 8½ weeks of age. At 10 weeks, they were infected with T. congolense. 
 
Mouse plasma and serum 
Fresh mouse serum was collected from female 5 to 8 week-old CD1 mice. Heat-
inactivated mouse serum was obtained by incubating fresh CD1 mouse serum at 56°C 
for 30 min. Plasma samples were collected from 8 to 10-week-old female BALB/c and 
C57BL/6 mice or 8½ week-old F2 mice into EDTA microtainer tubes (Becton 
Dickinson, Rutherford, N. J., USA).  
 
Preparation of peritoneal macrophages 
Peritoneal macrophages were isolated from 8 to 10-week-old (C57BL/6 and 
CD11b-deficient C57BL/6) mice 3 days following i.p. injection of 0.3 ml pristane 
(Sigma, Oakville, Ontario, Canada). Mice were euthanized by CO2. Peritoneal lavage 
was performed with 10 ml DMEM complete medium (DMEM medium supplemented 
with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 50 mM 2-
mercaptoethanol, and 100 IU of penicillin and streptomycin [Life Technologies, Grand 
Island, NY]). Collected peritoneal cells were washed twice in DMEM complete medium, 
and resuspended in DMEM complete medium. Peritoneal cells were allowed to adhere 
  
 
45 
to tissue culture plastic for 2 h at 370C, after which non-adhered cells were removed by 
rinsing the cell monolayer with medium (Shakibaei & Frevert, 1992). 
 
Test for covalent binding of C3 fragments onto T. congolense  
Plasma from two mouse strains (BALB/c and C57BL/6) was used in the assay. 
MgCl2 and EGTA (30 mM and 5 mM respectively) (Sigma, Oakville, Ontario, Canada) 
were added to plasma (Mg-EGTA plasma). T. congolense organisms (107) in 20 µl tris-
buffer-saline containing 1.25% glucose and 0.1% gelatin were added to 100 µl Mg-
EGTA plasma. Then, 2 µl of mAb 5A8 (IgM anti-VSG) was added to the plasma-
trypanosome mixture to give a final antibody to plasma dilution of 1:50. This dilution 
had previously been determined to be optimal for C3 deposition on trypanosomes. 
Incubation was done at 370C for 20 min, after which the reaction was stopped by placing 
the vial on ice. The mixture was spun at 1000 × g for 10 min, the supernatant aspirated, 
and the trypanosomes washed thrice with Tris-buffer-saline containing glucose and 
gelatin. After the final wash, trypanosomes were treated with 100 µl of 100 mM 
methylamine (Sigma) to elute covalently bound C3 fragments (Nilsson et al., 1989, 
Ogunremi et al., 1993). Controls included reactions of trypanosomes with Mg-EGTA 
plasma only (i.e. no anti-T. congolense mAb), as well as trypanosomes alone (i. e. no 
Mg-EGTA plasma). The C3 fragments present in the eluate were quantified using the C3 
sandwich ELISA as described (Ogunremi et al., 1993). ELISA results are expressed as 
C3 units, which were calculated from a standard curve of the OD405 readings of plasma 
C3 plotted against the log of dilutions of normal plasma (p< 0.01). 
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Phagocytosis of T. congolense in vitro 
Peritoneal macrophages were seeded in Lab-Tek 16-chamber glass slides 
(Electron Microscopy Sciences, Washington, USA) at 5×104 per well in 200 µl DMEM 
complete medium with 12 ng/ml IFN-γ (R&D systems, Minneapolis, USA) for 24 hr at 
370C. Then, the cells were washed 2x with DMEM. The macrophages were co-cultured 
with freshly isolated T. congolense (macrophages: trypanosome ratio = 1:10) in DMEM 
complete medium for 1 hr at 370 C. The medium in the phagocytosis experiments 
contained 50% fresh mouse serum instead of 10% heat-inactivated fetal bovine serum. 
MAb 6C1 (IgM anti-VSG) was added to cultures at various concentrations. After 
incubation, the chambers were rinsed with PBS, the plastic case removed, and the cells 
on the microscope slide were stained with fluorescent antibodies.  The percentage of the 
numbers of macrophages that had engulfed trypanosomes was determined by examining 
200 cells at random. The numbers of T. congolense ingested per macrophage were 
determined by using Northern Eclipse software from Empix Imaging Inc. (Mississauga, 
ON, Canada). The results for each experiment were obtained by examining 200 cells at 
random. In a preliminary experiment, the time course of phagocytosis (10, 20, 30, 60 
min) had been established. The phagocytosis reached the maximum at 60 min incubation 
of macrophages with T. congolense and IgM anti-VSG antibody (data not shown). The 
60 min incubation was used as a standard for the following experiments. In the presence 
of fresh mouse serum, phagocytosis of T. congolense by macrophages was assessed at 
antibody concentrations of 1.25 µg/ml, 2.5 µg/ml, 5 µg/ml, 10 µg/ml and 25 µg/ml.  
Phagocytosis of T. congolense by macrophages was found to occur in an antibody dose-
dependent pattern (data not shown). At the antibody concentration of 25 µg/ml, almost 
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100% of cells showed phagocytosis (data not shown). We used a sub-optimal antibody 
concentration (10 µg/ml) for the experiments described below. 
 
Immunocytochemistry 
Immunofluorescent double staining of macrophages that had engulfed 
trypanosomes has been described (Shi et al., 2004). 
 
TNF-α assays 
Peritoneal macrophages were cultured in 24-well plates at the concentration of 
6×105 cells/ml/well. Cells grown in DMEM complete medium contained 50% fresh 
mouse serum, instead of 10% heat-inactivated fetal bovine serum, served as negative 
control. The principal cultures contained macrophages plus T. congolense and mAb 6C1 
as described above (phagocytosis of T. congolense in vitro). The cell culture supernatant 
fluids were harvested after 4 hr incubation.  Culture supernatant fluids were centrifuged 
for 5 min at 1000 x g to remove cellular debris, transferred to new tubes, and stored at –
800 C until analysis. The levels of TNF-α in the culture supernatant fluids were 
determined by routine sandwich ELISA by using immulon-4 plates and TNF-α ELISA 
set (BD Biosciences Pharmingen, San Diego, CA), according to the manufacturer’s 
protocol. Each sample of cell culture fluid was tested for TNF-α in triplicate. The 
detection limit of the ELISA assays was 31 pg/ml.  
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Measurement of nitrite production 
Nitrite concentrations in the culture fluids harvested after 24 hr were determined 
by the “Griess reagent system” from Promega (Madison, WI, U.S.A.) as described 
previously (Kaushik et al., 1999).  Briefly, 50 µl of culture supernatant fluids were 
incubated with an equal volume of sulfanilamide solution (1% sulfanilamide [Sigma] in 
5% phosphoric acid [Sigma]) for 5-10 min at room temperature, protected from light. 
Then 50 µl of the NED (Sigma) (0.1% N-1-napthylethylenediamine dihydrochloride in 
water) was added and incubated for another 10 min at room temperature, protected from 
light. The absorbance was measured at 550 nm in a micro-ELISA reader. Nitrite levels 
were determined by comparison with a sodium nitrite (Sigma) standard curve. The 
sensitivity of this assay was 2.5 µM.  
 
Generation and detection of zymosan-bound complement C3 fragments 
The methods have been described previously (Ogunremi et al., 1993). Briefly, 
100 µl of mouse plasma containing 30 mM Mg2+ and 5 mM EGTA was incubated with 1 
mg zymosan (Sigma) for 10 min. Ca2+, which normally serves as a ligand in the 
trimolecular complex C1qrs of the classical pathway (Bryant & Jenkins, 1968), is not 
involved in the alternate pathway of complement activation (Fine, 1977). In contrast, 
Mg2+ is required for C3 convertase formation by both classical and alternate pathways 
(Muller-Eberhard et al., 1967, Pangburn et al., 1981). EGTA has a high affinity for Ca2+ 
but has a much lower association constant for Mg2+, and therefore allows activation by 
the alternate but not the classical pathway (Des Prez et al., 1975, Fine, 1977). The 
addition of Mg2+ to form MgEGTA allows optimum activation of the complement 
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alternative pathway (Des Prez et al., 1975, Fine, 1977). The zymosan was thoroughly 
washed and the C3 fragments eluted by treatment with 100 mM methylamine (Sigma) 
for 30 min at room temperature. The concentrations of eluted C3 fragments were 
determined by ELISA. 
 
Statistical analysis 
Data are presented as means ± standard error (SE). Analysis of Variance 
(ANOVA) and regression analysis were carried out using Excel software (Microsoft, 
Santa Monica, CA, USA). A P value < 0.05 was considered statistically significant. 
 
3.4 Results  
IgM anti-VSG mediates covalent binding of C3 fragments onto T. congolense 
Antibody-mediated lysis of T. brucei rhodesiense (Flemmings & Diggs, 1978) 
and T. congolense (Liu et al., 1993) occurs via activation of the alternative pathway of 
complement. We investigated whether IgM anti-VSG induces deposition of murine C3 
fragments onto T. congolense under conditions that favor activation of the alternative 
complement pathway. Live T. congolense were incubated with mouse plasma samples 
(containing 5 mM EGTA and 30 mM MgCl2) from C57BL/6 or BALB/c mice in the 
presence of IgM anti-VSG antibody. Murine C3 fragments were detectable on 
trypanosomes when the parasites were incubated with, but not without specific antibody 
(Fig 3.1). More C3 fragments were deposited onto the trypanosomes when the parasites 
were incubated with C57BL/6 plasma rather than with plasma derived from BALB/c 
mice (p< 0.05). These data indicate that IgM anti-VSG antibodies induce C3 fragments 
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to covalently bind onto T. congolense. They also show that the complement cascade of 
the relatively resistant C57Bl/6 mice allowed deposition of significantly more C3 
fragments onto T. congolense than the complement cascade of the susceptible BALB/c. 
 
FIGURE 3.1 
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FIGURE 3.1* IgM anti-VSG mediates covalent binding of C3 fragments onto T. 
congolense. T. congolense were incubated with EGTA/Mg++ plasma from C57BL/6 and 
BALB/c mice in the presence (+Ab) or absence (-Ab) of monoclonal IgM anti-VSG. 
The trypanosome-bound C3 fragments were eluted with 0.1 M methylamine. Eluted C3 
fragments were quantified by a sandwich ELISA consisting of a monoclonal anti-mouse 
C3 mAb 11H9 and a peroxidase-labelled goat anti-mouse C3 antiserum. Error bars show 
standard deviation from the mean of four separate experiments. 
* Data for Figure 3.1 were produced by Dele Ogunremi, and reported on page 84 in 
his PhD. Thesis (1993). 
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CR3 is the major macrophage receptor involved in IgM anti-VSG-mediated 
phagocytosis of T. congolense 
To assess whether CR3 is involved in IgM anti-VSG mediated phagocytosis of T. 
congolense, peritoneal macrophages from CD11b-deficient and normal mice were 
examined for phagocytosis of T. congolense in the presence of IgM anti-VSG antibody 
and fresh mouse serum. T. congolense was detected with the use of rabbit anti-T. 
congolense antiserum (red) and macrophages with the use of anti-F4/80 (green) by 
immunocytochemistry (Fig. 3.2). The intracellular localization of T. congolense ingested 
by macrophages was confirmed by comparing the immunocytochemistry results with 
and without permeabilization of cells by saponin (Fig. 3.2). There were significantly 
fewer (78%) T. congolense ingested per CD11b-deficient macrophage than per normal 
macrophage (1.31±0.23 vs. 5.88±1.20) (Fig. 3.3A). From the distribution data of the 
numbers of T. congolense ingested per macrophage, we observed that more than 50% of 
CD11b-deficient macrophages that did show phagocytosis ingested less than 2 parasites 
per cell. However, in more than 50% of normal macrophages that did show phagocytosis, 
2 to 8 parasites were ingested per cell (Fig. 3.3B). There were also significantly fewer 
(43%) CD11b-deficient macrophages than normal macrophages that showed 
phagocytosis of T. congolense (51.0±1.0% vs. 89.1±3.2%) (Fig. 3.4). These data indicate 
that CR3 is the major receptor involved in IgM anti-VSG-mediated phagocytosis of T. 
congolense by macrophages.  
Peritoneal macrophages from normal and CD11b-deficient mice were examined 
for phagocytosis of complement-opsonized T. congolense (incubated with fresh mouse 
serum) versus non-complement-opsonized T. congolense (incubated with heat-
inactivated mouse serum) in the presence of IgM anti-VSG antibody. Nearly equivalent 
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degrees of phagocytosis of T. congolense were observed under the following three 
conditions: (1) CD11b-deficient macrophages with fresh mouse serum and IgM anti-
VSG; (2) CD11b-deficient macrophages with heat-inactivated mouse serum and IgM 
anti-VSG; (3) normal mouse macrophages with heat-inactivated mouse serum and IgM 
anti-VSG. The numbers of T. congolense ingested per macrophage were 1.31±0.23, 
1.40±0.14 and 1.50±0.20, respectively (Fig. 3.3A). The proportions of macrophages that 
showed phagocytosis were 51±1.0%, 50.6±5.9% and 52.7±3.2%, respectively (Fig. 3.4). 
These data indicate that IgM-anti-VSG mediated phagocytosis via CR3 is a 
complement-dependent process. 
Peritoneal macrophages from CD11b-deficient and normal mice were also 
examined for up-take of T. congolense in the presence of fresh mouse serum but absence 
of IgM anti-VSG antibody. Immunocytochemistry results showed that, without IgM 
anti-VSG antibody, only a negligible number of T. congolense was ingested (Fig. 3.3A, 
3.4) by both kinds of macrophages. These data indicate that anti-VSG antibodies are 
necessary for effective phagocytosis of T. congolense by macrophages. This finding 
confirms our previous in vitro and in vivo results (Kaushik et al., 1999, Shi et al., 2004). 
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FIGURE 3.2 
 
 
 
 
 
 
 
 
 
 
 
FIGURE 3.2 IgM anti-VSG-mediated phagocytosis of T. congolense by murine 
peritoneal macrophages in the presence of fresh mouse serum. Normal peritoneal 
macrophages were incubated with T. congolense and IgM anti-VSG in the presence of 
fresh mouse serum. T. congolense was detected with the use of rabbit anti-T. congolense 
antiserum (red). Macrophage was detected with the use of anti-F4/80 (green) (1000× 
magnification). Cells were stained in the presence (A) or absence (B) of saponin that 
mediates permeabilization of the cell membrane.  
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 FIGURE 3.3 
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FIGURE 3.3 Phagocytosis of T. congolense by CD11b-deficient and normal 
macrophages: A, Numbers of T. congolense ingested per macrophage. B, Range of 
distribution of numbers of T. congolense ingested per macrophage. Peritoneal 
macrophages from CD11b-deficient mice or normal mice were incubated with T. 
congolense in the presence or absence of IgM anti-VSG and fresh mouse serum for 1hr 
at 370C.  T. congolense was detected with the use of rabbit anti-T. congolense antiserum 
(red). Macrophage was detected with the use of anti-F4/80 (green). T. congolense 
ingestion per macrophages was determined by measuring the red area (T. congolense 
antigen) in the green cell (macrophage) using Northern Eclipse software. In each 
experiment, 200 cells were examined at random. The data shown are the means of three 
separate experiments. 
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FIGURE 3.4 
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FIGURE 3.4 Phagocytosis of T. congolense by CD11b-deficient and normal 
macrophages: Numbers of T. congolense antigen-positive cells. Peritoneal 
macrophages from CD11b-deficient mice and normal mice were incubated with T. 
congolense in the presence or absence of IgM anti-VSG and fresh mouse serum for 1hr 
at 370C. T. congolense was detected with the use of rabbit anti-T. congolense antiserum 
(red). Macrophage was detected with the use of anti-F4/80 (green). The percent of 
macrophages that had engulfed trypanosomes was determined by examining 200 cells at 
random. The data shown are the means of three separate experiments. 
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Signaling via CR3, associated with IgM anti-VSG-mediated phagocytosis of T. 
congolense, affects synthesis of TNF-α 
We next investigated the role of CR3 in the synthesis of TNF-α. Peritoneal 
macrophages from CD11b-deficient and normal mice were stimulated with or without 
IFN-γ (12 ng/ml) for 24 hr, and then incubated with T. congolense with fresh mouse 
serum in the presence or absence of IgM anti-VSG. There was significantly less TNF-α 
(38% less) released by CD11b-deficient macrophages that had engulfed trypanosomes 
than by equally treated normal macrophages (991±69.4 pg/ml vs. 1594±29.7 pg/ml, 
respectively) (Fig. 3.5). The data indicate that synthesis of TNF-α,  associated with 
phagocytosis of T. congolense, is influenced by CR3 signaling either directly or 
indirectly. 
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FIGURE 3.5 
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FIGURE 3.5 Signaling via CR3, associated with IgM anti-VSG-mediated 
phagocytosis of T. congolense, affects synthesis of TNF-α. Peritoneal macrophages 
(6×105 cells per well) were seeded in 24-well plates in 1 ml DMEM complete medium 
with or without 12 ng IFN-γ for 24hr at 370C. Then the cells were cultured in DMEM 
with T. congolense (macrophage : trypanosome ratio = 1:10) in the presence of 50% 
fresh mouse serum and IgM anti-VSG mAb 6C1 (10 µg/ml). Negative control cultures 
consisted of cell cultures to which only DMEM and 50% fresh mouse serum was added. 
The cell culture supernatants were harvested after 4hr incubation.  The TNF-α 
concentrations of the supernatants were determined by routine sandwich ELISA. The 
data shown are from one experiment and are representative of four separate experiments. 
 
  
 
58 
Signaling via CR3, associated with IgM anti-VSG-mediated phagocytosis of T. 
congolense, inhibits synthesis of nitric oxide (NO) 
Macrophage-derived NO has been found to have a cytotoxic effect on T. brucei 
(Duleu et al., 2004) as well as on T. congolense (Kaushik et al., 1999). Peritoneal 
macrophages from CD11b-deficient and normal mice were stimulated with or without 
IFN-γ (12 ng/ml) for 24 hr, and then incubated with T. congolense in the presence of 
IgM anti-VSG and fresh mouse serum. Both CD11b-deficient and normal macrophages 
produced much less NO upon IgM anti-VSG-mediated phagocytosis when previously 
cultured without IFN-γ stimulation (Fig. 3.6). Although there were less T. congolense 
ingested, there was significantly more NO (63% more) released by CD11b-deficient 
macrophages that had engulfed trypanosomes than by equally treated normal 
macrophages (10.72±1.05 µM vs. 3.95±0.30 µM respectively) (Fig. 3.6). These data 
indicate that signaling via CR3, associated with IgM anti-VSG-mediated phagocytosis of 
T. congolense, either directly or indirectly inhibits NO synthesis. 
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FIGURE 3.6 
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FIGURE 3.6 Signaling via CR3, associated with IgM anti-VSG-mediated 
phagocytosis of T. congolense, inhibits synthesis of nitric oxide.  Peritoneal 
macrophages (6×105 cells per well) were seeded in 24-well plates at in 1 ml DMEM 
complete medium with or without 12 ng IFN-γ for 24 hr at 370C. Then, the cells were 
cultured in DMEM with T. congolense (macrophage: trypanosome ratio = 1:10) in the 
presence of 50% fresh mouse serum and mAb 6C1 (IgM anti-VSG) at a concentration of 
10 µg/ml. Negative control macrophage cultures contained neither trypanosomes nor 
antibodies. The cell culture supernatants were harvested after 24 hr incubation.  The 
nitrite concentrations of the supernatants were determined by the Griess reagent. The 
data shown are the means of four separate experiments.  
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Negative correlation between deposition of C3 fragments onto zymosan via the 
alternative pathway of complement and the survival period in T. congolense-infected 
progenies of BALB/c x C57BL/c crosses 
Since we found divergent effects of CR3 signaling for the synthesis of TNF-" 
and NO, we turned our attention to the ligand of CR3, i.e. iC3b, the degradation product 
of C3b. 
We previously observed differences in the activity of the alternative pathway of 
complement in BALB/c and C57BL/6 mice. Deposition of more C3b occurred when 
zymosan was incubated with C57BL/6 plasma (Ogunremi et al., 1993). BALB/c mice 
are highly susceptible to T. congolense infection whereas C57BL/6 mice are relatively 
resistant (Tabel et al., 2000). We also found more C3 fragments being deposited onto T. 
congolense when the parasite was incubated with plasma of C57BL/6 mice (Fig. 3.1). 
We asked the question whether deposition of different amounts of C3b onto target cells, 
via activation of the alternative complement pathway, might correlate with the genetic 
differences in resistance of mice to T. congolense infection. We infected 93 F2 mice 
from both reciprocal BALB/c x C57BL/6 crosses with 103 T. congolense. Prior to 
infection, we bled these mice and subjected each plasma sample to zymosan 
opsonization assay for determination of the amount of deposited C3b. We then assessed 
the correlation of amounts of deposited C3b and survival times of the infected mice. 
Rather than finding a positive correlation, which we had anticipated, we found a low, but 
statistically significant negative correlation (r=-0.32; p=0.002) (Fig. 3.7). Considering 
these observations, we suggest that deposition of C3b onto trypanosomes might not 
enhance but slightly decrease the chance of the host to resist T. congolense infection. 
Further, we suggest that the relatively resistant C57BL/6 mice might carry a 
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susceptibility gene coding for some, yet unknown protein of the alternative complement 
cascade. 
 
FIGURE 3.7 
 
0.0
5.0
10.0
15.0
20.0
25.0
30.0
0 50 100 150 200 250
Survival period (days)
C3
 
u
n
its
 
/ 1
00
 
µµ µµl
 
el
u
at
e
 
 
FIGURE 3.7* Relationship between deposition of complement C3 fragments onto 
zymosan and resistance to Trypanosoma congolense infection in F2 progeny of 
BALB/c x C57BL/6 crosses. Correlation was assessed by regression analysis: r = -0.32, 
p = 0.002. Each mouse was pre-bled for plasma (for zymosan opsonization assay) before 
infection. Results of the F2 mice from both reciprocal BALB/c x C57BL/6 crosses are 
presented (n = 93). Each mouse was infected with 103 T. congolense and monitored for 
survival period as an indication of resistance. Each data point represents one mouse. 
* Data for Figure3.7 were produced by Dele Ogunremi, and reported on page 93 in 
his PhD. Thesis (1993). 
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3.5 Discussion 
In the host defense system, macrophages play an important role through their 
ability to remove specific substances from the blood via various receptors, such as 
complement receptors, Fc-receptors, scavenger receptors and mannose receptors 
(Aderem & Underhill, 1999, Linehan et al., 2000). The control of parasitemia in African 
trypanosomiasis is mediated by at least two known mechanisms: (1) 
antibody/complement-mediated lysis and (2) antibody-mediated phagocytosis (Tabel et 
al., 2000). A possible third mechanism, i. e. release of trypanotoxic NO by macrophages 
after antibody-mediated phagocytosis remains controversial (Duleu et al., 2004, Gobert 
et al., 1998, Kaushik et al., 1999, Sternberg et al., 1994, Vincendeau & Daulouede, 
1991). IgM antibody plays an important role in the initial stages of immunity. IgM 
antibodies are the first predominant class of anti-trypanosomal antibodies in infections 
with African trypanosomes (Binz et al., 1968, Clarkson, 1976, Greenwood & Whittle, 
1973, Hudson et al., 1976, Luckins, 1976). IgM antibodies, after binding to antigen, are 
most efficient in activating the complement cascade (Law & Reid, 1988) and trigger 
abundant deposition of C3b. Our data show that C3 fragments covalently bind onto the 
parasites in the presence of IgM anti-VSG (Fig. 3.1). C3b covalently bound to target 
cells can quickly be degraded to iC3b by plasma factor I. In blood, C3b has a much 
shorter half life than iC3b (90 s vs. 45 min) (Cain et al., 1987, Ross, 1986). CR3, the 
receptor for iC3b, has been shown to be involved in phagocytosis of IgM-opsonized 
erythrocytes by murine Kupffer cells (Yan et al., 2000). We have shown that IgM anti-
VSG-opsonized T. congolense are phagocytosed by Kupffer cells in the liver (Shi et al., 
2004). 
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In the present work, we observed an important role for CR3 in IgM anti-VSG-
mediated phagocytosis of T. congolense by macrophages. We found that ingestion of 
IgM anti-VSG opsonized T. congolense by CD11b-deficient macrophages was 
consistently lower than that by normal macrophages, both by measuring the numbers of 
T. congolense ingested per macrophage (Fig. 3.3A, B) as well as the percentage of the 
numbers of macrophages that showed phagocytosis (Fig. 3.4). This indicated that CR3 is 
the main receptor involved in IgM anti-VSG-mediated phagocytosis of T. congolense, 
but is not the only receptor involved. The involvement of CR3 in phagocytosis of 
antibody-coated targets other than trypanosomes has been documented (Aderem & 
Underhill, 1999, Law & Reid, 1988, Yan et al., 2000). The existence of Fc receptors for 
IgM on murine and human T, B and NK cells as well as macrophages has been reported 
(Shibuya et al., 2000). Their biological significance in phagocytosis of pathogens 
remains to be determined.   
Several studies have reported that CR3, in addition to its role in complement-
opsonized phagocytosis, serves in the nonopsonic recognition of microbes by interacting 
directly with certain microbial molecules on their surfaces (Le Cabec et al., 2002, Yan et 
al., 2000). In the current study, we found that the IgM anti-VSG-mediated phagocytosis 
of T. congolense via CR3 is entirely complement-dependent. Equivalent degrees of 
phagocytosis of IgM anti-VSG-opsonized T. congolense by CD11b-deficient 
macrophages were observed, no matter whether functional complement was present or 
absent (Fig. 3.3A and 3.4). The ligand for CR3 is most likely iC3b, which is covalently 
bound to T. congolense by the activation of complement system via antibody-antigen 
complex (Fig. 3.1). The iC3b-coated parasites are then engulfed by macrophages via 
CR3. The localization of the relevant iC3b on T. congolense remains to be determined. 
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iC3b binds to the surface carbohydrate of antigens (Law & Reid, 1988). Since the C3-
fragments covalently bound to T. congolense could be eluted by methylamine (Fig. 3.1), 
it is safe to assume that they were bound to trypanosomal carbohydrate. We speculate 
that they were bound to trypanosomal GIP. 
Since CR3 deficiency was not associated with a complete lack of IgM anti-VSG-
mediated phagocytosis of T. congolense, other receptors must be involved in this process. 
The relevant receptors are presently unknown. We consider the mannose receptor a 
possible candidate (Linehan et al., 2000). Anti-VSG antibodies induce T. congolense to 
shed VSG (Liu et al., 1993) (see below). This process might expose invariant surface 
epitopes, such as the conserved VSG carbohydrates (Gerold et al., 1996, Magez et al., 
2002). Mannose receptor of macrophages might recognize these carbohydrate epitopes 
and further mediate phagocytosis.  
We also demonstrated that IgM anti-VSG-mediated phagocytosis of T. 
congolense via CR3 receptor by macrophages is associated with signaling of TNF-α 
synthesis. Studies have shown that deposition of complement component onto the 
surface of Group B Streptococcus (GBS) and subsequent CD11b-mediated activation is 
the central mechanism by which plasma or serum potentiates GBS-induced TNF-α 
release from human monocytes in culture and in whole blood (Levy et al., 2003). 
Bacterial internalization via CR3 (CD11b/CD18) accounts for a substantial fraction of 
the induction of cytokine (TNF-α) signaling (Moore et al., 2000). We observed that 
significantly less TNF-α was released by CD11b-deficient macrophages that had 
engulfed trypanosomes than by equally treated normal macrophages (Fig. 3.5). These 
data indicate that CR3-signaling, associated with IgM anti-VSG-mediated phagocytosis 
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of T. congolense, either directly or indirectly enhances synthesis of TNF-α. However, 
other, yet unknown receptors must be involved. TLR2 is a potential candidate. For 
example, stimulation of TLR2 by glycosylphosphatidylinositol from Trypanosma cruzi 
was found to induce synthesis of TNF-α in macrophages (Campos et al., 2001).  
Induction of tumor necrosis factor (TNF-α) and its role in immunopathology has 
been extensively documented in African trypanosomiasis (Hunter et al., 1991, Magez et 
al., 1999, Magez et al., 2002, Okomo-Assoumou et al., 1995, Sileghem et al., 1994b). 
Enhanced expression of TNF-α in the brains of Trypanosoma brucei-infected mice has 
been reported (Hunter et al., 1991). Associations have been found between TNF-α 
production by monocytes and the severity of disease-associated anemia in trypanosome-
infected cattle (Sileghem et al., 1994b), neuropathological symptoms in human sleeping 
sickness patients (Okomo-Assoumou et al., 1995), trypansosome-elicited 
immunosuppression and overall morbidity (Magez et al., 1999). It is tempting to 
speculate that CR3-mediated phagocytosis of T. congolense in the presence of IgM 
antibody might contribute to enhanced trypanosomiasis-associated immunopathology by 
increasing synthesis of TNF-α. 
On the other hand, the results presented in this study support the conclusion that 
signaling via CR3, associated with IgM antibody-mediated phagocytosis of T. 
congolense, either directly or indirectly inhibit the synthesis of NO. Our data showed 
that CD11b-deficient macrophages that had engulfed fewer trypanosomes produced 
significantly more NO than equally treated normal macrophages (Fig. 3.6). Activated 
macrophages express inducible NO synthase (iNOS) which synthesizes large amounts of 
NO by oxidation of L-arginine (Munder et al., 1998). It has been reported that T. brucei 
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brucei directly activates arginase, another enzyme that metabolizes L-arginine. When 
the arginase pathway is activated, it inhibits NO production (Duleu et al., 2004). The 
observed enhanced NO production in CD11b-deficient mice could be either due to a 
reduced inhibitory signal by CR3 or due to a reduced inhibitory, intracellular signal 
because of less intracellular trypanosomes. Presently it is unknown which mechanism 
might have been operating. Our previous studies on phagocytosis of T. congolense by 
bone marrow-derived macrophages from both C57BL/6 and BALB/c mice showed that 
phagocytosis of T. congolense mediated by anti-VSG antibodies of IgG2a isotype 
induced two- to nine-fold more NO than phagocytosis mediated by IgM antibodies 
(Kaushik et al., 1999). Increase of IgM anti-VSG correlated with decreased NO 
production (Kaushik et al., 1999). It has been observed that TLR5/TLR4 complexes are 
involved in NO synthesis signaling of macrophages stimulated with bacterial flagellin 
(Mizel et al., 2003). Macrophage mannose receptors may also be involved in NO 
synthesis signaling (Karaca et al., 1995). 
NO has been shown to be trypanostatic for T. congolense, T. musculi, and T. 
brucei in vitro (Duleu et al., 2004, Gobert et al., 1998, Kaushik et al., 1999, Vincendeau 
& Daulouede, 1991, Vincendeau et al., 1992). Peritoneal macrophages and bone 
marrow-derived macrophages from resistant C57BL/6 mice produce significantly higher 
NO than macrophages of susceptible BALB/c mice in response to T. congolense 
(Kaushik et al., 1999). Therefore, NO may at least partially account for differences in 
resistance to T. congolense infection. Thus, we speculate that stimulation of CR3 during 
IgM anti-VSG-mediated phagocytosis of T. congolense impairs control of parasitemia 
by inhibiting NO production, and thus reducing the cytostatic effect on T. congolense. If 
this hypothesis proves to be correct, it might explain why enhanced deposition of C3b 
  
 
67 
onto target cells correlates with susceptibility rather than resistance to T. congolense 
infection (Fig. 3.7). 
CR3 contributes to both beneficial and detrimental effects for controlling the 
disease. The beneficial effect is that CR3 is one of the receptors involved in antibody-
mediated phagocytosis, which is a major immune response mediating control of 
parasitaemia (Dempsey & Mansfield, 1983, Macaskill et al., 1980, Pinder et al., 1986, 
Shi et al., 2003). Stimulation of CR3 during IgM anti-VSG-mediated phagocytosis 
increases synthesis of TNF-α that enhances trypanosomiasis-associated 
immunopathology (Hunter et al., 1991, Magez et al., 1999, Okomo-Assoumou et al., 
1995, Sileghem et al., 1994b) and inhibits synthesis of NO that is involved in 
cytotoxicity to T. brucei and T. congolense (Duleu et al., 2004, Gobert et al., 1998, 
Kaushik et al., 1999, Vincendeau & Daulouede, 1991). 
In conclusion, the results presented in this report indicate that CR3 is the major 
receptor involved in IgM anti-VSG mediated phagocytosis of T. congolense. We suggest 
that signaling via CR3 during IgM anti-VSG-mediated phagocytosis of trypanosomes 
enhance disease by increased synthesis of TNF-α and by decreased NO-mediated 
control of parasitemia. 
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4. RELESAE OF SOLUBLE VARIANT SURFACE GLYCOPROTEIN 
FROM TRYPANOSOMA CONGOLENSE: EFFECT OF ANTIBODY AND 
COMPLEMENT 
 
4.1 Abstract 
The surfaces of African trypanosomes are covered with a layer of a single 
species of glycoprotein, called variant surface glycoprotein (VSG). Soluble VSG (sVSG) 
has been reported to induce polyclonal B cell activation, to induce macrophages to 
produce TNF-α and inhibit macrophages to synthesise NO. In this study, we assessed the 
effect of IgM anti-VSG antibody on the release of sVSG from T. congolense. We found 
that there was more sVSG released from T. congolense by interaction with IgM anti-
VSG than by interaction with equal amounts of IgG2a anti-VSG. The release of sVSG 
occurred in an antibody dose-dependent pattern. We also found that IgM anti-VSG 
forms soluble immune complexes with sVSG. The results also showed that antibody-
induced release of sVSG can occur without complement, but is enhanced by 
complement. We further tested the effect of the source of complement on the release of 
sVSG from T. congolense by using fresh mouse serum from either relatively resistant 
C57BL/6 mice or highly susceptible BALA/c mice. The results showed that, antibody-
induced shedding of sVSG was higher in the presence of fresh C57BL/6 serum than in 
the presence of fresh BALB/c serum. Although this result could imply a beneficial effect 
of sVSG in resistance, other studies, as discussed in this thesis, indicate the opposite. All 
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these data suggest that the concentration of anti-VSG antibody, antibody class and 
complement can affect the release of sVSG from T. congolense. 
 
4.2 Introduction 
African trypanosomes are extracellular parasites causing sleeping sickness in 
humans and nagana in livestock. Trypanosoma congolense is the most important 
trypanosome species responsible for nagana in livestock (Hursey & Slingenbergh, 1995). 
The entire parasite surface is covered with a layer of a single species of glycoprotein, 
called variant surface glycoprotein (VSG) (Cross, 1990). Each parasite expresses about 
107 densely packed identical VSG molecules on its surface (Cross, 1990, Gerold et al., 
1996)). African trypanosomes have developed a very sophisticated mechanism of 
antigenic variation (Cross, 1990). The parasites will sequentially express a different 
VSG gene that is antigenically distinct from the previously expressed (El-Sayed et al., 
2000, Ferrante & Allison, 1983). Antigenic variation permits the trypanosome 
population as a whole to keep “one step ahead”of the immune response. By this process, 
the parasites evade the immune system of their host to permit themselves to survive 
within the host (El-Sayed et al., 2000).  
Molecules of VSG, the major component of the trypanosomal surface coat, are 
arranged in a tightly packed monolayer forming a 12-15 nm thick coat (Borst et al., 
1998). They account for about 10% of the total amount of protein and are constitutively 
synthesized at a high rate (about 8% of total protein biosynthesis) (Kang et al., 2002). 
Each VSG monomer contains a N-terminal signal sequence and a hydrophobic C-
terminal domain and is covalently attached to a glycosylphosphatidylinositol (GPI) 
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membrane anchor (Ferguson et al., 1985, Ferguson & Williams, 1988, Gerold et al., 
1996, Kang et al., 2002). VSG coats are stably associated with the parasite plasma 
membrane but can be isolated as the membrane form of VSG (mfVSG) or the freely 
water-soluble glycoproteins (sVSG) after cell lysis. mfVSG is readily converted to 
sVSG during cell lysis by the action of an endogenous enzyme, the GPI-specific 
phospholipase C (GPI-PLC) (Ferguson, 1999). This GPI-PLC can cleave the GPI anchor, 
leaving the dimyristoylglycerol (DMG) compound of the mfVSG in the membrane, and 
release the glycosyl-inositol-phosphate (GIP)-VSG part (also called soluble VSG 
[sVSG]) (Fox et al., 1986, Magez et al., 1998).  
There is growing evidence that VSG released from the parasite surface, is 
involved in affecting functions of macrophages, including the induction of synthesis of 
cytokines, such as TNF-α (Magez et al., 2002, Paulnock & Coller, 2001), and inhibiting 
IFN-γ-induced nitric oxide production (Coller et al., 2003). sVSG also has been found to 
induce polyclonal B cell activation (Diffley, 1983). The released sVSG from T. brucei 
can cause consumption of complement proteins, which may occur via the tremendous 
amounts of immune complexes generated during antibody-mediated clearance at each 
wave of parasitaemia (Musoke & Barbet, 1977). There is evidence that T. congolense 
bloodstream forms might evade complement lysis by shedding of immune complexes 
(Frevert & Reinwald, 1990). Several studies have also documented the 
immunostimulatory and regulatory activity of GPI anchors derived from T. brucei and 
other protozoa (Magez et al., 2002, Ropert & Gazzinelli, 2000, Tachado et al., 1997, 
Tachado & Schofield, 1994).  
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The release of VSG can be induced by hypotonic lysis (Cardoso De Almeida et 
al., 1999) or by different kinds of stress in vitro (Bowles & Voorheis, 1982, Rolin et al., 
1996). In different strains of trypanosome-infected mice, the parasites are regularly 
confronted with the antibody specific for VSG and the complement cascades consisting 
of potentially different alleles of components. Antibody-induced release of sVSG has 
been reported (Liu et al., 1993). Within a narrow range of antibody concentration, the 
release of soluble VSG was correlated with the amount of antibody added to the mixture 
(Liu et al., 1993). There are no reports on the effect of antibody class or isotype 
regarding the release of sVSG from the trypanosomes, or the potential effects of 
different alleles of complement components. 
In this study, we tried to get answers to the following questions: 1) Is the release 
of sVSG from T. congolense affected by the dosage or the class/isotype of antibody 
against VSG? 2) Does some released sVSG remain in a soluble complex with anti-VSG 
antibody? 3) Is the amount of sVSG released by antibody interaction affected by (a) 
complement and (b) by the source of complement? 4) Is some of the released sVSG 
present in a covalent complex with complement component C3b?  
We incubated T. congolense with different amounts of IgM anti-VSG or IgG2a 
anti-VSG in the presence of 50% fresh mouse serum at 370C, and then tested the sVSG 
in the supernatants by western blot. We found that the release of sVSG occurs in an 
antibody dose-dependent pattern, and that more sVSG is released from T. congolense by 
interaction with IgM anti-VSG than by interaction with equal amounts of IgG2a anti-
VSG. By immunprecipitation experiments, we also found that IgM anti-VSG forms 
soluble immune complexes with sVSG during the release from the surface of T. 
congolense. The results also show that antibody-induced release of sVSG occurs in the 
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absence of complement, but the release of sVSG can be enhanced by adding 
complement. We further tested the effect of the source of complement on the release of 
sVSG from T. congolense. T. congolense was incubated with anti-VSG antibody and 
fresh C57BL/6 serum or fresh BALB/c serum at 370C. The subsequent sVSG release 
into the culture supernatants of the incubation mixtures were tested by western blot. The 
results showed that, with the same amount of anti-VSG antibody, there was more sVSG 
released in the presence of fresh serum from C57BL/6 mice than in the presence of 
BALB/c serum. The biological significance of more sVSG being released by interaction 
with IgM anti-VSG, and in the presence of fresh C57BL/6 mouse serum will be 
discussed. These data suggest that the release of sVSG from the surface of T. congolense 
is affected in an antibody-dosage dependent pattern. The amount of sVSG released also 
depends on the antibody class and the source of complement. 
 
4.3 Material and methods 
Parasite 
T. congolense, Trans Mara strain, variant antigenic type (VAT) TC13 was used 
in this study. The origin of this parasite strain has been previously described (Tabel, 
1982). Frozen stabilates of parasites were used for infecting CD1 mice 
immunosuppressed with cyclophosphamide, and passages were made every third day as 
described previously (Tabel, 1982). The parasites purified from the blood of infected 
CD1 mice by DEAE-cellulose chromatography (Lanham & Godfrey, 1970). 
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Mice 
Eight to 10 week-old, female, C57BL/6 and BALB/c mice and 5 to 8 week-old, 
female, Swiss white mice (CD1) were purchased from the Animal Resource Center of 
the University of Saskatchewan (Saskatoon, Canada). The mice were kept in 
polycarbonate cages on sawdust, and allowed free access to food and water throughout 
the experiments, according to the recommendations of the Canadian Council of Animal 
Care. 
 
Fresh mouse serum and heat-inactivated mouse serum 
Blood was collected from female 8 to 10 week-old C57BL/6 and BALB/c mice, 
and 5 to 8 week-old CD1 mice. The blood was allowed to clot and spun at 600×g at 40C 
to separate fresh serum. Serum samples were dispensed in aliquots and stored at –800C 
until use. Heat-inactivated mouse serum was obtained by incubating fresh CD1 mouse 
serum at 560C for 30 min. 
 
Antibody 
The production of the polyclonal rabbit anti-T. congolense (Shi et al., 2003), and 
of monoclonal antibodies (mAb) 6C1 (IgM), 5A8 (IgM) and 1D11 (IgG) specific for the 
VSG of VAT TC13 has been described (Wei et al., 1990). Peroxidase-labelled mouse 
anti-Rabbit IgG (H+L) was obtained from Jackson ImmunoResearch Lab. (West Grove, 
PA, USA). Mouse IgM (isotype control) was obtained from SeroTec Inc. (Raleigh, NC, 
USA). Goat anti-mouse IgM (µ chain-specific) was obtained from Cappel (MP 
Biomedicals, Irvine, CA, USA). 
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Buffer and Reagents 
Tris-saline buffer with glucose (TSG) contained 17.5 g/L Tris (Sigma, Oakville, 
Ontario, Canada), 4.75 g/L Sodium Chloride (Sigma, Oakville, Ontario, Canada), 100 
ml/L 1N hydrochloric acid and 12.5 g/L glucose (Sigma, Oakville, Ontario, Canada), pH 
7.8. Phosphate buffered saline (PBS) contained 0.262 g/L sodium phosphate monobasic, 
1.15 g/L sodium phosphate dibasic heptahydrate and 8.5 g/L sodium chloride, pH 7.2. 
Phosphate buffered saline with tween-20 (PBST) contained 0.5 ml/L Tween-20 (Sigma, 
Oakville, Ontario, Canada). BenchMark pre-stained protein ladder was obtained from 
Invitrogen Inc. (Burlington, Ontario). 
 
Procedure of antibody-mediated release of sVSG 
T. congolense were mixed with anti-VSG antibody (IgM or IgG) and 50% fresh 
mouse serum in TSG. T. congolense mixed with mouse IgM isotype control (25 µg/ml) 
and 50% fresh mouse serum in TSG, served as one control. T. congolense mixed with 
50% fresh mouse serum in TSG without antibody, served as another control. The 
mixtures were incubated at 370C for 30 min, and then centrifuged at 13,000 x g at 40C 
for 15 min. The supernatants were collected and stored at –800C until analysis (modified 
from (Liu et al., 1993)). The kinetics of the release of sVSG with time of incubation was 
determined (Appendix 5). 
 
Western blot for testing for sVSG 
The sVSG-containing supernatants (described above) were separated by SDS-
PAGE with 10% separating gels in a Mini-protean II apparatus (Bio-Rad, Richmond, 
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CA 94804). Samples diluted in non-reducing buffer were boiled for 5 min before 
loading onto the gel. Electrophoresis was carried out at 200 V until the dye marker 
reached the gel bottom. After SDS-PAGE was carried out, the protein bands were 
transferred from the gel to a nitrocellulose membrane in a Wet Transfer Cell (BIO-RAD 
Apparatus) at 75 V at 40C for 2 hr. The nitrocellulose membrane was then washed with 
PBS and blocked in 5% skim milk (DIFCO, Marland, USA) in PBS at 40C overnight. 
Then the nitrocellulose membrane was washed with PBST and incubated with rabbit 
anti-T. congolense antiserum in 2.5% skim milk (DIFCO) in PBST at RT for 1 hr. After 
washing, the last incubation was done with peroxidase-labelled mouse anti-rabbit IgG 
(H+L) at RT for 45 min. After washing again, the color development was carried out 
with HRP color development reagent. Partly purified sVSG was run with the samples as 
a positive control, which has been described (Liu et al., 1993). The results were scanned 
and the band densities were measured by AlphaImager 2000 software (Alpha Innotech 
Corporation, San Leandro, CA, USA). 
 
Testing for the IgM anti-VSG/sVSG immune complexes 
sVSG supernatants were prepared by interaction with T. congolense, IgM anti-
VSG and fresh CD1 mouse serum as described above. The supernatant from IgM 
isotype control and negative control were also prepared as described above. One more 
control was added for testing whether IgM anti-VSG would bind to the released sVSG. 
The supernatant from the mixture of T. congolense and 50% fresh CD1 mouse was 
prepared following the protocol as described above, and then mixed with IgM anti-VSG 
(25 µg/ml) for another incubation at 370C for 30 min. The supernatant, which contain 
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sVSG and IgM anti-VSG antibody, was collected after centrifugation at 13,000 x g at 
40C for 15 min. The parasites were discarded with the pellet. 
All the supernatants were mixed with goat anti-mouse IgM in the presence of 10 
mM EDTA at RT for 1 hr. The mixtures were then centrifuged at 13,000 x g at 40C for 
15 min. The precipitates were washed with PBS and then suspended in PBS/1% SDS. 
The precipitates were then analyzed by western blot with rabbit anti-T. congolense 
antiserum (as western blot for testing sVSG). 
 
Statistical analysis 
Data are presented as means ± standard error (SE). Analysis of Variance 
(ANOVA) was carried out using Excel software (Microsoft, Santa Monica, CA, USA). 
A P value < 0.05 was considered statistically significant. 
 
4.4 Results 
The anti-VSG induced release of sVSG from T. congolense depends on antibody 
concentration  
 
First we tested whether the release of sVSG from T. congolense was affected by 
the anti-VSG antibody dosage. T. congolense were incubated at 370C for 30 min with 
different amounts of anti-VSG antibody (IgM 6C1 or IgG2a 1D11) in the presence of 
50% fresh mouse serum from CD1, C57BL/6 or BALB/c mice. The supernatants were 
collected and tested by western blot with rabbit anti-T. congolense antiserum. We found 
that the parasites released more sVSG when the antibody concentration was increased. 
This happened when the parasites were allowed to interact with either IgM anti-VSG 
(6C1) or IgG2a anti-VSG (1D11) in the presence of different sources of fresh mouse 
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serum (Fig 4.1, 4.2, 4.3). These data indicate that the release of sVSG from T. 
congolense occurs in an antibody dose-dependent pattern. 
The results also show that two bands of higher molecular weight could be 
detected in the samples prepared in the presence of anti-VSG antibody and fresh mouse 
serum but could not be detected in the absence of anti-VSG antibody. The band density 
of these two bands increased with the IgM anti-VSG concentration. The molecular 
weights of these two bands were about 210 kD and 105 kD respectively. These two 
bands could be other parasite antigen released by complement-mediated lysis. On the 
other hand, they could be covalently bound complexes of sVSG, and degradation 
products of complement component C3. 
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FIGURE 4.1 
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FIGURE 4.1 IgM anti-VSG induces the release of sVSG from T. congolense. In the 
presence of 50% fresh CD1 mouse serum, T. congolense (108/ml) were mixed with 
different amounts of IgM anti-VSG (mAb 6C1). The mixtures were incubated at 370C 
for 30 min, and then spun down 15 min at 13,000 g at 40C for separating the supernatant. 
The supernatants were tested for sVSG by Western blot (1# Ab: rabbit anti-T. 
congolense antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit IgG (H+L)).  
Lane 1: partly purified sVSG 
Lane 2: mouse IgM (isotype control) + T. congolense +fresh mouse serum 
Lane 3: No antibody + T. congolense + fresh mouse serum 
Lane 4: IgM anti-VSG1.25 µg/ml + T. congolense + fresh mouse serum 
Lane 5: IgM anti-VSG 2.5 µg/ml + T. congolense + fresh mouse serum 
Lane 6: IgM anti-VSG 5 µg/ml + T. congolense + fresh mouse serum 
Lane 7: IgM anti-VSG 10 µg/ml + T. congolense + fresh mouse serum 
Lane 8: IgM anti-VSG 25 µg/ml + T. congolense + fresh mouse serum 
Lane 9: BenchMark prestained protein ladder.  
IgM anti-VSG(µg/ml) 
(µg/ml) 
sVSG 
177.6 kD 
113.9 kD 
81.2 kD 
47.4 kD 
36.1 kD 
25.3 kD 
19.0 kD 
“VSG-C3b” 
“VSG-C3d” 
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FIGURE 4.2  
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FIGURE 4.2 IgG anti-VSG induces the release of sVSG from T. congolense. In the 
presence of 50% fresh CD1 mouse serum, T. congolense (108/ml) were mixed with 
different amounts of IgG anti-VSG (mAb 1D11). The mixtures were incubated at 370C 
for 30 min, and then spun down 15 min at 13,000 g at 40C for separating the supernatant. 
The supernatant were tested for sVSG by Western blot (1# Ab: rabbit anti-T. congolense 
antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit IgG (H+L)).  
Lane 1: partly purified sVSG 
Lane 2: No antibody + T. congolense + fresh mouse serum 
Lane 3: IgG2a anti-VSG1.25 µg/ml + T. congolense +fresh mouse serum 
Lane 4: IgG2a anti-VSG 2.5 µg/ml + T. congolense +fresh mouse serum 
Lane 5: IgG2a anti-VSG 5 µg/ml + T. congolense +fresh mouse serum 
Lane 6: IgG2a anti-VSG 10 µg/ml + T. congolense +fresh mouse serum 
Lane 7: IgG2a anti-VSG 25 µg/ml + T. congolense +fresh mouse serum 
Lane 8: BenchMark prestained protein ladder.  
 
IgG2a anti-VSG (µg/ml) 
(µg/ml)
177.6 kD 
113.9 kD 
81.2 kD 
47.4 kD 
36.1 kD 
25.3 kD 
19.0 kD sVSG 
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FIGURE 4.3 
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FIGURE 4.3 Antibody induces the release of sVSG from T. congolense in the 
presence of fresh C57BL/6 or BALB/c mouse serum. T. congolense (107/ml) were 
incubated with (A) IgM anti-VSG (mAb 6C1) and 50% fresh C57BL/6 serum; (B) 
IgG2a anti-VSG (mAb 1D11) and 50% fresh C57BL/6 serum; (C) IgM anti-VSG (mAb 
6C1) and 50% fresh BALB/c serum; (D) IgG2a anti-VSG (mAb 1D11) and 50% fresh 
BALB/c serum were tested by Western blot (1# Ab: rabbit anti-T. congolense antiserum, 
2# Ab: peroxidase-labelled mouse anti-rabbit IgG (H+L)). The set of results shown is 
representative of three similar experiments. 
Lane 1: No antibody + T. congolense + fresh mouse serum 
Lane 2: anti-VSG 1.25 µg/ml + T. congolense + fresh mouse serum 
Lane 3: anti-VSG 5 µg/ml + T. congolense + fresh mouse serum 
Lane 4: partly purified sVSG 
A 
B 
C 
D 
IgM anti-VSG 
IgM anti-VSG 
IgG2a anti-VSG 
IgG2a anti-VSG 
C57BL/6 serum 
BALB/c serum 
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IgM anti-VSG is more efficient than IgG2a anti-VSG in inducing shedding of sVSG 
from T. congolense 
Then, we assessed whether the class of antibody would affect the efficiency of 
release of sVSG from T. congolense. The supernatants from T. congolense were 
incubated with equal amounts of IgM anti-VSG or IgG2a anti-VSG in the presence of 
fresh CD1 serum. The supernatants of the mixtures were tested for sVSG by western 
blot with rabbit anti-T. congolense antiserum. We measured the band densities by 
Alphaimage software. The results showed that, in the presence of fresh mouse serum, 
there was more sVSG released from T. congolense by interaction with IgM anti-VSG 
than by interaction with IgG2a anti-VSG (band densities: 448.9 ± 40.8 vs 295.1 ± 14.3, 
respectively. p=0.012) (Fig 4.4). These results indicate that IgM anti-VSG is more 
efficient than IgG2a anti-VSG in inducing T. congolense to release sVSG.  
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FIGURE 4.4 
 
 
 
 
 
 
FIGURE 4.4 IgM anti-VSG induces the release of more sVSG from T. congolense 
than IgG2a anti-VSG. The sVSG supernatant form the culture of T. congolense (108/ml) 
mixed 50% of fresh CD1 mouse serum and same amount of IgM anti-VSG (mAb 6C1) 
(25 µg/ml) or IgG2a anti-VSG (mAb 1D11) (25 µg/ml) were tested by Western blot (1# 
Ab: rabbit anti-T. congolense antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit 
IgG (H+L)). The band densities were measured by Alphaimager software, and shown in 
the bottom line. The mean band density of sVSG released by interacted with IgM anti-
VSG is 448.9 ± 40.8, and by interacted with IgG2a anti-VSC is 295.1 ± 14.3 (p=0.012). 
The set of results shown is representative of two similar experiments. 
 
     -           +              -           +              -          +             -             + 
    +            -              +           -             +           -             +             - 
 
  295        540          313       486         316       414        254      354 
IgM anti-VSG 
IgG2a anti-VSG 
Band density 
  
 
83 
After interaction with T. congolense, some IgM anti-VSG remains in a soluble 
complex with the shed sVSG 
We further tested whether IgM anti-VSG can occur in a soluble immune 
complex with sVSG after sVSG had been released from T. congolense. T. congolense 
was incubated with fresh mouse serum and IgM anti-VSG antibody and the supernatants 
were subjected to immunoprecipitation by anti-mouse IgM antibody. The precipitates 
were tested for sVSG by western blot with rabbit anti-T. congolense antiserum. No 
sVSG was detectable in the precipitate of two different control preparations: (a) 
supernatant derived from mixture of T. congolense and fresh CD1 mouse serum (Fig. 4.5 
lane 1) and (b) supernatant of (a) that was spiked with IgM anti-VSG (Fig. 4.5 lane2). A 
strong band of sVSG could be detected in the precipitate obtained from the supernatant 
of incubated mixtures of T. congolense, IgM anti-VSG and fresh mouse serum (Fig. 4.5, 
lane 3). A very faint band of sVSG was detectable in the supernatant derived from the 
incubated mixture of T. congolense, 25 µg/ml mouse IgM (normal antibody control) and 
fresh CD1 mouse serum (Fig 4.5 lane 4). These data indicate that IgM anti-VSG, after 
interaction with the surface of T. congolense, can remain in a soluble complex with 
sVSG when sVSG was released. The result obtained with the normal antibody control 
suggests that some natural IgM might weakly react with VSG of T. congolense and 
induce the release of very low amount of sVSG and remain bound to sVSG. 
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FIGURE 4.5 
 
 
 
 
FIGURE 4.5 Some IgM anti-VSG remains in a soluble immune complex with sVSG 
after sVSG is released from the surface of T. congolense. IgM/anti-IgM 
immunoprecipitations were carried out using the supernatants from the following 
incubated mixtures: The set of results shown is representative of two similar 
experiments. 
Lane 1: T. congolense (108/ml) + 50% fresh CD1 mouse serum (control) 
Lane 2: Like above, but after incubation and centrifugation, 25 µg/ml IgM anti-VSG 
was added to the supernatant (control) 
Lane 3: T. congolense (108/ml) + 50% fresh CD1 mouse serum + 25 µg/ml IgM anti-
VSG 
Lane 4: T. congolense (108/ml) + 50% fresh CD1 mouse serum + 25 µg/ml mouse IgM 
The precipitates from the immunoprecipitation were tested for sVSG by western blot (1# 
Ab: rabbit anti-T. congolense antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit 
IgG (H+L)).  
 
             1                     2                       3                         4 
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Antibody against VSG can induce release of sVSG in the absense of complement 
activity 
We tested the ability of anti-VSG antibody to induce the release of sVSG from T. 
congolense in the absence of active complement by using heat-inactivated (56oC / 30 
min) CD1 mouse serum. T. congolense (108/ml) was incubated with different amounts of 
IgM anti-VSG (mAb 6C1) in the presence of 50% heat-inactivated CD1 mouse serum. 
The supernatant of the incubated mixtures were tested for sVSG by western blot with 
rabbit anti-T. congolense antiserum. We found that, without active complement, the 
parasites released more sVSG with increasing antibody concentrations (figure 4.6). 
Antibody-induced release of sVSG from T. congolense can occur independently of 
complement. Antibody-induced release of sVSG in the absence of complement also 
proceeds in a dose- dependent pattern (figure 4.6).  
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FIGURE 4.6 
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FIGURE 4.6 IgM anti-VSG induces the release of sVSG from T. congolense in the 
absence of fresh mouse serum. In the presence of 50% heat-inactivated CD1 mouse 
serum, T. congolense (108/ml) were mixed with different amount of IgM anti-VSG 
(mAb 6C1). The mixture was incubated at 370C for 30 min, and then spun down 15 min 
at 13,000 x g at 40C for separating the supernatant. The sVSG in the supernatant were 
tested by Western blot (1# Ab: rabbit anti-T. congolense antiserum, 2# Ab: peroxidase-
labelled mouse anti-rabbit IgG (H+L)).  
Lane 1: partly purified sVSG 
Lane 2: No antibody + T. congolense + heat-inactivated mouse serum 
Lane 3: IgM anti-VSG1.25 µg/ml + T. congolense + heat-inactivated mouse serum 
Lane 4: IgM anti-VSG 2.5 µg/ml + T. congolense + heat-inactivated mouse serum 
Lane 5: IgM anti-VSG 5 µg/ml + T. congolense + heat-inactivated mouse serum 
Lane 6: IgM anti-VSG 10 µg/ml + T. congolense + heat-inactivated mouse serum 
Lane 7: IgM anti-VSG 25 µg/ml + T. congolense + heat-inactivated mouse serum 
Lane 8: BenchMark prestained protein ladder.  
IgM anti-VSG (µg/ml) 
(µg/ml) 
177.6 kD 
113.9 kD 
81.2 kD 
47.4 kD 
36.1 kD 
25.3 kD 
19.0 kD 
sVSG 
  
 
87 
Antibody-induced shedding of sVSG from T. congolense is higher in the presence of 
serum complement  
To assess whether the source of complement would affect the release of sVSG 
from T. congolense, complement from C57BL/6, BALB/c and CD1 mice were used. T. 
congolense (108/ml) was incubated with IgM anti-VSG (mAb 6C1: 25 µg/ml) in the 
presence of 50% fresh mouse serum with or without 10 mM EDTA (an inhibitor of 
complement activation). The supernatants from the incubated mixtures were tested for 
sVSG by western blot with rabbit anti-T. congolense antiserum. The results showed that 
more sVSG was released from T. congolense by IgM anti-VSG in the presence of fresh 
mouse serum than in the presence of EDTA/fresh mouse serum (Fig. 4.7). These data 
indicate that antibody-induced release of sVSG can occur without complement (presence 
of EDTA), but the complement activation enhances the release of sVSG from the 
parasites. Two bands of higher molecular weight, which have beed discussed above (Fig 
4.1), could be detected in samples prepared in the presence of fresh mouse serum 
without EDTA but could not be detected in samples prepared in the presence of fresh 
mouse serum with EDTA.  
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FIGURE 4.7 
 
 
                                            +       -          +       -         +      - 
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FIGURE 4.7 More IgM anti-VSG-induced release of sVSG from T. congolense was 
found in the presence than in the absence of complement activation, and fresh 
serum from C57BL/6 mice is more effective in enhancing antibody-induced release 
of sVSG than fresh serum from BALB/c or CD1 mice. T. congolense (108/ml) was 
incubated with IgM anti-VSG (mAb 6C1 10 µg/ml) and 50% fresh mouse serum with or 
without 10 mM EDTA. The supernatant of the mixtures were tested for sVSG by 
Western blot (1# Ab: rabbit anti-T. congolense antiserum, 2# Ab: peroxidase-labelled 
mouse anti-rabbit IgG (H+L)). The density of sVSG bands were measured by 
Alphaimager software, and are showed in the bottom line.  
Lane 1: partly purified sVSG 
Lane 2: fresh CD1 serum/10 mM EDTA + T. congolense (108/ml) + IgM anti-VSG  
Lane 3: fresh CD1 serum + T. congolense (108/ml) + IgM anti-VSG 
Lane 4: fresh BALB/c serum/10 mM EDTA + T. congolense (108/ml) + IgM anti-VSG 
Lane 5: fresh BALB/c serum + T. congolense (108/ml) + IgM anti-VSG  
Lane 6: fresh C57BL/6 serum/10 mM EDTA + T. congolense (108/ml) + IgM anti-VSG 
Lane 7: fresh C57BL/6 serum + T. congolense (108/ml) + IgM anti-VSG  
Lane 8: BenchMark prestained protein ladder. 
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Fresh serum of C57BL/6 mice enhances antibody-induced shedding of sVSG more 
than fresh serum from BALB/c mice 
T. congolense were incubated with different amounts of IgM anti-VSG in the 
presence of 50% fresh mouse serum from either C57BL/6 or BALB/c mice. The 
supernatants from the incubated mixtures were tested for sVSG by western blot. The 
results showed that T. congolense released more sVSG by interaction with IgM anti-
VSG in the presence of fresh C567BL/6 serum than in the presence of fresh BALB/c 
serum or CD1 serum (Fig. 4.7, 4.8). Similar results were found by using IgG anti-VSG 
(Appendix 9.7). These findings indicate that the source of complement can affect the 
antibody-induced shedding of sVSG from T. congolense. Complement from the 
relatively resistant C57BL/6 mice is more effective than complement from the 
susceptible BALB/c mice in enhancing the antibody-induced release of sVSG. 
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FIGURE 4.8  
 
 
 
 
 
 
FIGURE 4.8 More sVSG is released from T. congolense by interaction with IgM 
anti-VSG in the presence of fresh C57BL/6 serum than in the presence of fresh 
BALB/c serum. T. congolense (107/ml) was incubated with different amounts of IgM 
anti-VSG (mAb 6C1) and 50% fresh C57BL/6 serum or fresh BALB/c serum. The 
supernatant of the mixtures were tested for sVSG by Western blot (1# Ab: rabbit anti-T. 
congolense antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit IgG (H+L)). The 
band densities were measured by Alphaimage software. The set of results shown is 
representative of two similar experiments. 
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4.5 Discussion 
Since African trypanosomes are extracellular parasites, any sVSG shed from the 
parasites are released into the circulation. sVSG has been found in the plasma of mice 
infected with T. brucei (Diffley et al., 1980, Paulnock & Coller, 2001, Weitz, 1960) and 
T. congolense (Tabel unpublished). The immune system of an infected mammalian host 
is regularly confronted with these circulating sVSG (Magez et al., 2002). GPI-PLC-
mediated VSG release is part of the parasite biology (Black et al., 1982, Seyfang et al., 
1990, Shapiro, 1986). In the infected mice, the trypanosomes are faced with the antibody 
specific to VSG and the complement system. We tested the effect of the class of 
antibody against VSG, the influence of complement, and the potential source of 
complement on the release of sVSG from T. congolense by in vitro experiments. The use 
of 50% of fresh mouse serum mimicked the in vivo condition as closely as possible.  
In this study, the results showed that, the antibody-induced release of sVSG from 
T. congolense occurs in a dose-dependent pattern (Fig. 4.1, 4.2, 4.3), and includes both a 
complement-independent and -dependent pathway (Fig. 4.6, 4.7). Our results showed 
that the antibody-induced complement-independent release of sVSG occurs in a dose-
dependent pattern (Fig. 4.6), and complement activation enhances the antibody-induced 
release of sVSG from T. congolense (Fig. 4.7). 
The results also showed that IgM anti-VSG is more effective in inducing release 
sVSG than IgG2a anti-VSG (Fig. 4.4). This may directly be due to the 10 valent binding 
potential of one molecule of IgM anti-VSG onto the VSG epitopes exposed at the 
surface of the parasite. Alternatively, it may be indirectly due to IgM being more 
efficient in inducing complement-mediated parasite lysis. It has been reported that cross 
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linking of VSG molecules, such as trypanosomes treated with IgG anti-VSG, caused the 
rapid accumulation of ligands along the line of flagellar attachment and their shedding 
by formation of coat-covered vesicles and filopodia (Frevert & Reinwald, 1988, 
Shakibaei & Frevert, 1992). IgM antibodies, after binding to antigen, are most efficient 
in activating the complement cascade (Law & Reid, 1988). Our data also showed that 
some IgM anti-VSG remains in a soluble immune complex with sVSG after the sVSG 
has been released from the surface of T. congolense (Fig 4.5). It has previously been 
suggested that shedding of immune complexes might be a method by which 
trypanosomes evade complement-mediated lysis (Frevert & Reinwald, 1990). IgM 
antibodies are the first and predominant class of anti-trypanosomal antibodies in African 
trypanosomes infections (Binz et al., 1968, Clarkson, 1976, Greenwood & Whittle, 1973, 
Hudson et al., 1976, Luckins, 1976). IgM anti-VSG is equally efficient in inducing 
phagocytosis of T. congolense by macrophages as IgG2a anti-VSG (Kaushik et al., 1999, 
Shi et al., 2004). Here, we show that IgM anti-VSG is more efficient in inducing release 
of sVSG from the parasites. sVSG has been shown to have detrimental effects in 
trypanosomal infections. sVSG has been shown to induce polyclonal B cell activation 
(Diffley, 1983). sVSG can activate macrophages to produce TNF-α (Magez et al., 2002, 
Paulnock & Coller, 2001), which plays an important role in the immunopathology of 
African trypanosomiasis (Hunter et al., 1991, Magez et al., 1999, Magez et al., 2002, 
Okomo-Assoumou et al., 1995, Sileghem et al., 1994b). sVSG also has the ability to 
inhibit IFN-γ-induced production of nitric oxide (Coller et al., 2003) which is 
trypanotoxic (Duleu et al., 2004, Gobert et al., 1998, Kaushik et al., 1999, Sternberg et 
al., 1994, Vincendeau & Daulouede, 1991). All these observations suggest that IgM anti-
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VSG antibody, although being able to mediate phagocytosis and lysis of the parasite, 
also mediates detrimental effects by its ability to induce the release of sVSG from the 
parasites. 
In T. congolense infection, BALB/c mice are highly susceptible whereas 
C57BL/6 mice are relatively resistant (Ogunremi & Tabel, 1995, Pinder, 1984). After 
infection with 103 T. congolense, the mean survival time of BALB/c mice is 8.4±0.5 
days, but the C57BL/6 mice control the first peak of parasitemia and survive for more 
than 5 months (Ogunremi & Tabel, 1995). Our data showed that, after binding of anti-
VSG antibody to T. congolense, there was more sVSG released in the presence of fresh 
C57BL/6 serum than in the presence of fresh BALB/c serum (Fig 4.7). It was also found 
in our lab that, in the presence of anti-VSG antibody and T. congolense, more 
complement-mediated lysis of T. congolense occurred with fresh C57BL/6 serum than 
with fresh BALB/c serum (data not shown). Therefore, more sVSG released in the 
presence of fresh C57Bl/6 serum might be due to the fact that more complement-
mediated parasite lysis occurs with fresh C57BL/6 serum than with fresh BALB/c serum. 
This conclusion is in line with the previous observation that the complement cascade of 
the relatively resistant C57Bl/6 mice allowed deposition of significantly more C3 
fragments onto T. congolense than the complement cascade of the susceptible BALB/c 
(Fig. 3.1). This observation suggests that genetic polymorphism may affect the effiency 
of complement activation, such that the complement cascade of C57BL/6 and BALB/c 
mice is different and differently affects parasite clearance. The more efficient activation 
of the complement cascade in T. congolense infected C57BL/6 mice might, however, 
have diverse effects on controlling the disease. The enhanced release of sVSG in the 
presence of fresh C57BL/6 serum might have a negative effect on controlling infections. 
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It has been observed that sVSG induces TNF-α synthesis in macrophages (Paulnock & 
Coller, 2001) and inhibits synthesis of NO by IFN-γ-stimulated macrophages (Coller et 
al., 2003). On the other hand, this negative effect might be outweighed by C57BL/6 
mice being more efficient in inducing more complement-mediated lysis of the parasite. 
In conclusion, the results shown here indicate that antibody-induced release of sVSG 
occurs in a dose-dependent pattern. There is more sVSG released from T. congolense by 
interaction with IgM anti-VSG than by interaction with equal amounts of IgG anti-VSG. 
The antibody-induced release of sVSG from T. congolense occurs in the absence of 
complement, but is enhanced by the presence of complement. The data also show that 
complement from relatively resistant C57BL/6 mice is more effective than complement 
from the susceptible BALB/c mice in enhancing the antibody-induced release of sVSG. 
All these data suggest that the release of sVSG from T. congolense is affected by the 
dosage and the class of the anti-VSG antibody, and also affected by the source of 
complement. 
 
  
 
95 
5. GENERAL DISSCUSSION AND CONCLUSION 
The aim of this thesis work was to test the effect of IgM anti-VSG on T. 
congolense. It was shown that, in the presence of fresh mouse serum, the interaction of 
IgM anti-VSG with T. congolense could cause several immune reactions.  
It had previously been observed that IgM anti-VSG can mediate phagocytosis of 
parasites by macrophages in vitro and in vivo (Kaushik et al., 1999, Shi et al., 2004). 
The receptor(s) on the macrophages involved in IgM anti-VSG-mediated phagocytosis 
of African trypanosomes has been unknown. 
The present study shows that CR3 (CD11b/CD18) is the major receptor involved 
in IgM anti-VSG mediated phagocytosis of T. congolense. The IgM anti-VSG-mediated 
phagocytosis of T. congolense via CR3 is entirely complement-dependent. The signaling 
via CR3, associated with IgM anti-VSG-mediated phagocytosis of T. congolense, either 
directly or indirectly enhances the TNF-α production, but inhibits NO synthesis.  
The biological significance of CR3 in T. congolense infections appears to be 
multi-faceted. The function of CR3 in T. congolense infections is beneficial in 
controlling the parasitemia through its ability to mediate phagocytosis of IgM anti-VSG-
coated parasites. On the other hand, the modulation of macrophage functions subsequent 
to phagocytosis of trypanosomes has to be taken into account. There is evidence that 
high levels of TNF-α produced by macrophages contribute to disease in African 
trypanosomiasis (Hunter et al., 1991, Magez et al., 1999, Magez et al., 2002, Okomo-
Assoumou et al., 1995, Sileghem et al., 1994b). NO secreted by macrophages appears to 
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be beneficial to the host since it is cytotoxic for extracellular trypanosomes (Duleu et al., 
2004, Gobert et al., 1998, Kaushik et al., 1999, Vincendeau & Daulouede, 1991, 
Vincendeau et al., 1992). It has been shown in this thesis that phagocytosis of 
trypanosomes via CR3 inhibits NO synthesis. It is presently not clear what the net 
effects of the functions of CR3 are in T. congolense infections. I suggest that the overall 
contribution of CR3 signaling might, especially in the susceptible host, be negative 
rather than positive. This tentative conclusion requires confirmation by in vivo 
experiments. Other receptors involved in this process are presently unknown. The 
mannose receptor (Linehan et al., 2000) and Toll-like receptors (Campos et al., 2001) 
are possible candidates. 
The release of sVSG from T. congolense by the interaction of IgM anti-VSG 
with parasites was studied. The data of this study show that IgM anti-VSG induces the 
release of sVSG from T. congolense more effectively than IgG anti-VSG. Some IgM 
anti-VSG persists in a soluble immune complex with sVSG. The antibody-induced 
release of sVSG can occur without complement, and is enhanced by complement. Anti-
VSG antibody-mediated release of sVSG from T. congolense is more enhanced in the 
presence of complement from C57BL/6 mice than the complement from BALB/c mice.  
The parasitemia in African trypanosomiasis is believed be controlled by three 
different mechanisms: (1) antibody/complement-mediated lysis (Flemmings & Diggs, 
1978), (2) antibody-mediated phagocytosis (Tabel et al., 2000) and (3) trypanotoxic NO 
secreted by macrophages after antibody-mediated phagocytosis (Duleu et al., 2004, 
Gobert et al., 1998, Kaushik et al., 1999, Vincendeau & Daulouede, 1991). 
The biological role of IgM anti-VSG in the disease is complex. IgM anti-VSG 
contributes to the control of the T. congolense infection by mediating phagocytosis and 
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lysis of the parasite. The beneficial effects of lysis and phagocytosis of the parasite 
might be outweighed by the ability of IgM anti-VSG to mediate enhanced synthesis of 
TNF-α but decreased synthesis of trypanotoxic NO. In addition, excessively shed sVSG 
might bind newly synthesized anti-VSG and thus prevent this newly produced antibody 
from mediating lysis and phagocytosis of the parasite. 
The data of this study also show that complement plays an important role in IgM 
anti-VSG-mediated phagocytosis of T. congolense as well as in the antibody-induced 
release of sVSG from T. congolense. Complement contributes to control the parasitemia 
by antibody/complement-mediated lysis and by complement component iC3b-mediated 
phagocytosis of IgM antibody-coated trypanosomes. On the other hand, complement 
enhances the release of sVSG from trypanosomes. Soluble VSG has been shown to be 
contributing to the detrimental effects in trypanosome infection by enhancing synthesis 
of TNF-" (Paulnock & Coller, 2001) but inhibiting synthesis of NO (Campos et al., 
2001, Coller et al., 2003, Magez et al., 2002).  
Several differences have been found between the complement from relatively 
resistant C57BL/6 and highly susceptible BALB/c mice. Firstly, under conditions that 
allowed activation of the alternative pathway of complement, more C3 fragments were 
deposited onto zymosan in the presence of fresh serum from C57Bl/6 than that of 
BALB/c mice (Ogunremi et al., 1993). Secondly, when incubated with IgM anti-VSG, 
more complement C3 fragments were deposited onto T. congolense in the presence of 
fresh C57BL/6 serum than in the presence of fresh BALB/c serum (Fig.3.1). Thirdly, 
complement from C57BL/6 mice is more efficient in enhancing the anti-VSG antibody-
mediated release of sVSG from T. congolense than complement from BALB/c mice 
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(Fig.4.7, 4.8). Fourthly, more IgM anti-VSG/complement-mediated lysis of T. 
congolense occurs in the presence of fresh C57BL/6 serum than in the presence of fresh 
BALB/c serum (Tabel, unpublished.).  
Deposition of more C3 fragments onto T. congolense will contribute to 
controlling the parasitemia by IgM antibody-mediated phagocytosis via CR3. However, 
as discussed above, the modulation of macrophages associated with CR3-mediated 
phagocytosis inhibits synthesis of NO by these cells and presumably reduces the 
potential control of parasitemia by NO. It was also shown that deposition of C3 
fragments onto zymosan has a low, but statistically significant, negative correlation with 
the survival of F2 mice [BALB/c Χ C57BL/6] infected with T. congolense. Therefore, 
the overall contribution of complement to resistance and pathogenesis of 
trypanosomiasis is complex. Whether the superior trypanolytic activity of complement 
of the relatively resistant C57BL/6 mice might represent an innate factor of resistance 
against infection and/or disease remains to be determined. If so, there should be one or 
more relevant differences in complement genes of C57BL/6 and BALB/c mice. Such 
gene(s) should be located within one of the identified quantitative trait loci (Kemp et al., 
1997). 
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6. FUTURE DIRECTIONS 
Based on the studies in this thesis, many questions have been brought up that, if 
answered, would shed more light on the role of IgM anti-VSG in T. congolense 
infections.  
(1) The role of NO in controlling the parasitemia in vivo. The signaling via CR3, 
associated with IgM anti-VSG-mediated phagocytosis, inhibits NO synthesis. 
NO has been shown to be trypanostatic for T. congolense, T. musculi, T. 
gambiense and T. brucei in vitro (Kaushik et al., 1999, Vincendeau & Daulouede, 
1991, Vincendeau et al., 1992). These results beg the question: does NO 
contribute to controlling the parasitemia in vivo? The question could be 
answered by infecting nitric oxide synthase-deficient mice. Also, arginase 
activity, which is competing with the iNOS pathway, should be measured (Duleu 
et al., 2004). 
(2) The receptors for IgM anti-VSG-mediated phagocytosis of T. congolense other 
than CR3. CR3 deficiency is not associated with a complete lack of IgM anti-
VSG-mediated phagocytosis of T. congolense, which means other receptors must 
be involved in this process. The relevant receptors are presently unknown. Are 
the mannose receptor (Linehan et al., 2000) and Toll-like receptor (Campos et al., 
2001) possible candidates? The potential role of mannose receptor in 
phagocytosis of T. congolense could be detected by using soluble mannan, which 
can block the function of mannose receptor (Karaca et al., 1995). 
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(3) In the experiments concerned with the release of sVSG, two top bands could 
always be detected by western blot (Fig.4.1, 4.2, 4.7). They could be detected in 
samples prepared in the presence of fresh mouse serum and anti-VSG antibody, 
but could not be detected in samples prepared in the presence of heat-inactivated 
serum or EDTA/fresh mouse serum. The molecular weights of these two bands 
were about 210 kD and 105 kD respectively. These two bands could be other 
parasite antigen released by complement-mediated lysis. On the other hand, they 
could be complexes of sVSG covalently bound to degradation products of 
complement component C3, such as VSG-C3b and VSG-C3d. These complexes 
might have biological significance. It has been reported that antigen covalently 
bound to C3d is up to 1000-fold more immunogenic than native antigen (Fearon 
& Carroll, 2000). Are these two bands in fact complexes of VSG and C3 
fragments? This could be tested by anti-C3 antibody. 
(4) This investigation did not in any way clarify the mechanism of IgM-antibody-
mediated release of sVSG. It has been reported that anti-trypanosomal antibodies 
induce the formation and shedding of VSG-coated filopodia (Shakibaei & 
Frevert, 1992). Dose IgM anti-VSG antibody induce the formation and release of 
VSG-coated filopodia? 
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8.      APPENDIX 
8.1 IgM anti-VSG-mediated phagocytosis of Trypanosoma congolense by a 
macrophage cell line occurs in an antibody dose-dependent pattern  
Aim 
To test whether the degree of phagocytosis of T. congolense by macrophages correlates 
with the concentration of IgM anti-VSG antibody 
Protocol 
1. Cells of macrophage cell line BALB.BM were seeded in Lab-Tek 16-chamber 
glass slides (Electron Microscopy Sciences, Washington, USA) at 5 × 104 cells 
per well in 200 µl DMEM complete medium with 12 ng/ml IFN-γ (R&D systems, 
Minneapolis, USA) for 24 hr at 370C.  
2. The cells were washed 2x with DMEM. The mixture of freshly isolated T. 
congolense (macrophage: trypanosome ratio = 1:10) with 50% fresh CD1 mouse 
serum and different amounts of IgM anti-VSG were added to the cells and 
cultured for 1 hr at 370 C 
3.  After incubation, the chambers were rinsed with PBS, the plastic case removed, 
and the cells were stained by fluorescent antibody technique. 
Results and conclusion 
Immunocytochemistry results showed that, in the presence of fresh mouse serum, 
more T. congolense had been engulfed by macrophages when the IgM anti-VSG 
concentration had been increased. Without IgM anti-VSG antibody, only a negligible 
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number of T. congolense were ingested. At antibody concentration 25 µg/ml, almost 
100% of cells showed phagocytosis. 
This result indicates that IgM anti-VSG-mediated phagocytosis of T. congolense 
by macrophages occurs in a dose-dependent pattern. 
Figure 8.1  
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Figure 8.1 IgM anti-VSG mediates phagocytosis of T. congolense by macrophages 
cell line occurs in an antibody-dose-dependent pattern. Macrophages (BALB.BM 
cell line) were incubated with T. congolense for 60 min in the presence of 50% fresh 
CD1 mouse serum with different amounts of IgM anti-VSG (mAb 6C1. Phagocytosis of 
T. congolense was detected by immunocytochemical double staining. T. congolense was 
detected with the use of rabbit anti-T. congolense antiserum (red). Macrophages were 
detected with the use of anti-F4/80 (green) (400× magnification).  
A B C 
D E F 
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8.2 IgM anti-VSG-mediated phagocytosis of Trypanosoma congolense by 
macrophages increases with time of incubation (using BALB.BM cell line) 
Aim 
To test whether IgM anti-VSG-mediated phagocytosis of T. congolense by macrophages 
will increase with time of incubation  
Protocol 
1. Cells of macrophage cell line BALB.BM were seeded in Lab-Tek 16-chamber 
glass slides (Electron Microscopy Sciences, Washington, USA) at 5 × 104 cells 
per well in 200 µl DMEM complete medium with 12 ng/ml IFN-γ (R&D systems, 
Minneapolis, USA) for 24 hr at 370C.  
2. The cells were washed 2x with DMEM. The mixture of freshly isolated T. 
congolense (macrophage: trypanosome ratio = 1:10) with IgM anti-VSG (mAb 
6C1) (25 µg/ml) and 50% fresh CD1 mouse serum were added in the cell and 
cultured for different period of time at 370 C. 
3.  After incubation, the chambers were rinsed with PBS, the plastic case removed, 
and the cells were stained by fluorescent antibody technique. 
Results and conclusion 
Immunocytochemistry results showed that more IgM anti-VSG-mediated 
phagocytosis of T. congolense occurred with increasing time of incubation. The 
phagocytosis reached the maximum at an incubation time of 60 min. This result 
indicates that there is a positive correction between the degree of the IgM anti-VSG-
mediated phagocytosis of T. congolense and time of incubation. 
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Figure 8.2  
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Figure 8.2 IgM anti-VSG-mediated phagocytosis of T. congolense by macrophages 
increases with time of incubation. Macrophages (BALB.BM cell line) were incubated 
with T. congolense and IgM anti-VSG (mAb 6C1) (25 µg/ml) in the presence of 50 % 
fresh CD1 mouse serum for different periods of time (2 min, 5 min, 10 min, 30 min and 
60min). Phagocytosis of T. congolense was detected by immunocytochemical double 
staining.  T. congolense was detected with the use of rabbit anti-T. congolense antiserum 
(red). Macrophages were detected with the use of anti-F4/80 (green) (400× 
magnification).  
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8.3 IgM anti-VSG-mediated phagocytosis of Trypanosoma congolense by 
CD11b-deficient or by normal peritoneal macrophages occurs in an 
antibody-dose-dependent pattern  
Aim 
To test whether the phagocytosis of T. congolense by macrophages from CD11b-
deficient and normal mice will increase with increase of the concentration of IgM anti-
VSG antibody  
Protocol 
1. Peritoneal macrophages were isolated from 8 to 10-week-old wild-type and 
CD11b-deficient C57BL/6 mice 3 days following i.p. injection of 0.3 ml pristane 
(Sigma, Oakville, Ontario, Canada). Peritoneal cells were collected, washed 
twice in DMEM complete medium, and resuspended in DMEM complete 
medium. Peritoneal cells were allowed to adhere to plastic tissue culture dishes 
for 2 h at 370C, after which non-adhered cells were removed by rinsing the cell 
monolayer with medium. 
2. Peritoneal macrophages from CD11b-deficient and normal C57BL/6 mice were 
seeded in Lab-Tek 16-chamber glass slides (Electron Microscopy Sciences, 
Washington, USA) at 5×104 cells per well in 200 µl DMEM complete medium 
with 12 ng/ml IFN-γ (R&D systems, Minneapolis, USA) and incubated for 24 hr 
at 370C.  
4. The cells were washed 2x with DMEM. The mixture of freshly isolated T. 
congolense (macrophage: trypanosome ratio = 1:10), 50% fresh CD1 mouse 
  135 
serum and different amounts of IgM anti-VSG were added to the cells and 
cultured for 1 hr at 370 C. 
5.  After incubation, the chambers were rinsed with PBS, the plastic case removed, 
and the cells on the microscope slide were stained with fluorescent antibodies. 
Results and conclusion 
Immunocytochemistry results showed that, in the presence of fresh mouse serum, 
the degree of IgM anti-VSG-mediated phagocytosis of T. congolense correlated with the 
increase of the antibody concentration. This happened with both normal and CD11b-
deficient macrophages. Without IgM anti-VSG antibody, only a negligible number of T. 
congolense were ingested in both kinds of macrophages. At an antibody concentration of 
25 µg/ml, almost 100% of cells from normal mice showed phagocytosis. There was a 
clear difference of phagocytosis between CD11b-deficient and normal macrophages at 
an antibody concentration of 10 µg/ml. The difference did not increase at higher 
antibody concentration. 
These results indicate that IgM anti-VSG-mediated phagocytosis of T. 
congolense by macrophages from CD11b-deficient or normal mice occur in a dose-
dependent pattern.  
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Figure 8.3  
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Figure 8.3 IgM anti-VSG-mediated phagocytosis of T. congolense by peritoneal 
macrophages from CD11b-deficient or normal C57BL/6 mice occur in an antibody-
dose-dependent pattern. Macrophages from CD11b-deficient (Lane A) and normal 
C57BL/6 mice (Lane B) were incubated with T. congolense and different amounts of 
IgM anti-VSG (mAb 6C1) in the presence of 50% fresh CD1 mouse serum for 60 min. 
Phagocytosis of T. congolense was detected by immunocytochemical double staining. T. 
congolense was detected with the use of rabbit anti-T. congolense antiserum (red). 
Macrophages were detected with the use of anti-F4/80 (green) (200× magnification).  
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8.4 CR3 is the major receptor on macrophages involved in IgM anti-VSG-
mediated phagocytosis of Trypanosoma congolense  
Aim 
To test whether CR3 is one of the receptors involved in IgM anti-VSG-mediated 
phagocytosis of T. congolense 
Protocol 
1. Peritoneal macrophages were isolated from 8 to 10-week-old wild-type and 
CD11b-deficient C57BL/6 mice 3 days following i.p. injection of 0.3 ml pristane 
(Sigma, Oakville, Ontario, Canada). Collected peritoneal cells were washed 
twice in DMEM complete medium, and resuspended in DMEM complete 
medium. Peritoneal cells were allowed to adhere to plastic tissue culture dishes 
for 2 h at 370C, after which non-adhered cells were removed by rinsing the cell 
monolayer with medium. 
2. Peritoneal macrophage from CD11b-deficient and normal C57BL/6 mice were 
seeded in Lab-Tek 16-chamber glass slides (Electron Microscopy Sciences, 
Washington, USA) at 5×104 cell per well in 200 µl DMEM complete medium 
with 12 ng/ml IFN-γ (R&D systems, Minneapolis, USA) and incubated for 24 hr 
at 370C.  
3. The cells were washed 2x with DMEM. The mixture of freshly isolated T. 
congolense (macrophage: trypanosome ratio = 1:10), IgM anti-VSG (mAb 6C1) 
(10 µg/ml) and 50% fresh CD1 mouse serum were added to the cells and 
cultured for 1 hr at 370 C. 
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4.  After incubation, the chambers were rinsed with PBS, the plastic case removed, 
and the cells on the microscope slide were stained by fluorescent antibody 
technique. 
Results and conclusion 
Immunocytochemistry results showed that, in the presence of fresh mouse serum, 
there occurred more IgM anti-VSG-mediated phagocytosis of T. congolense by normal 
macrophages than by CD11b-deficient macrophages. Without IgM anti-VSG antibody, 
only a negligible number of T. congolense were ingested in both kinds of macrophages. 
Without complement, a similar degree of phagocytosis was observed between normal 
and CD11b-deficient macrophages. The intracellular localization of T. congolense 
ingested by macrophages was confirmed by comparing the immunocytochemistry results 
i.e. when the procedure was preformed with (Group 1, 2, 3) or without (Group 4, 5) 
permeabilization of the cells by saponin. 
These results indicate that CR3 (CD11b/CD18) is one of the receptors on 
macrophages involved in IgM anti-VSG-mediated phagocytosis of T. congolense, and 
the IgM anti-VSG-mediated phagocytosis of T. congolense via CR3 is entirely 
complement-dependent. 
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Figure 8.4 CR3 is the major receptor on macrophages involved in IgM anti-VSG-
mediated phagocytosis of T. congolense. Macrophages from CD11b-deficient (Lane A) 
and normal C57BL/6 mice (Lane B) were incubated with T. congolense and IgM anti-
VSG (mAb 6C) (10 µg/ml) in the presence or absence of 50% fresh CD1 mouse serum 
for 60 min. Phagocytosis of T. congolense was detected by immunocytochemical double 
staining. T. congolense was detected with the use of rabbit anti-T. congolense antiserum 
(red). Macrophages were detected with the use of anti-F4/80 (green) (200× 
magnification). The intracellular localization of T. congolense ingested by macrophages 
was confirmed by comparing the immunocytochemistry results with (Group 1, 2, 3) and 
without (Group 4, 5) permeabilization of cells by saponin. 
Group 1: T. congolense + IgM anti-VSG + 50% fresh mouse serum 
(permeabilization of cells by saponin)  
Group 2: T. congolense + IgM anti-VSG + 50% heat-inactivated mouse serum 
(permeabilization of cells by saponin) 
Group 3: T. congolense + 50% fresh mouse serum (permeabilization of cells by 
saponin) 
Group 4: T .congolense + IgM anti-VSG + 50% fresh mouse serum (no 
permeabilization of cells by saponin)  
Group 5: T. congolense + IgM anti-VSG + 50% heat-inactivated mouse serum (no 
permeabilization of cells by saponin) 
 
Group 5 
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8.5 Release of sVSG from Trypanosoma congolense by interaction with anti-
VSG antibody correlates with the time of incubation  
Aim 
To test whether antibody-induced release of sVSG from T. congolense is affected by the 
incubation time 
Protocol 
1. 108 /ml T. congolense were mixed with anti-VSG antibody (the concentration of 
IgM mAb 6C1, IgG2a mAb1D11 or mouse IgM was 25 µg/ml) and 50% fresh 
CD1 mouse serum in TSG. The mixtures were incubated at 370C for different 
periods of time, and then centrifuged at 13,000 x g at 40C for 15 min. The 
supernatants were collected. 
2. The sVSG in the supernatants were tested by western blot. Rabbit anti-T. 
congolense antiserum was used as first antibody, and peroxidase-labelled mouse 
anti-rabbit IgG (H+L) as second antibody.  
Results and conclusion 
Western blot results showed that the degree of release of sVSG from T. congolense 
correlated with the time of incubation. These results indicate that optimal anti-VSG-
induced release of sVSG from T. congolense requires about 60 min. 
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Figure 8.5 
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Figure 8.5 The degree of anti-VSG antibody-induced shedding of sVSG from T. 
congolense correlates with increase of incubation time. In the presence of 50% fresh 
CD1 mouse serum, T. congolense (108/ml) were mixed with IgM anti-VSG (mAb 6C1) 
(A), IgG anti-VSG (mAb 1D11)(B) or mouse IgM (isotype control)(C). The mixtures 
were incubated at 370C for different period of time, and, for separating the supernatant, 
they were spun down for 15 min at 13,000 x g at 40C. The sVSG in the supernatants 
were detected by Western blot (1# Ab: rabbit anti-T. congolense antiserum, 2# Ab: 
peroxidase-labelled mouse anti-rabbit IgG (H+L)).  
Lane 1: incubation time 0min  
Lane 2: incubation time 2 min  
Lane 3: incubation time 5 min  
Lane 4: incubation time 10 min  
Lane 5: incubation time 20 min  
Lane 6: incubation time 30 min  
Lane 7: incubation time 60 min  
Lane 8: partly purified sVSG 
A 
B 
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8.6 Fresh serum from C57BL/6 mice enhances IgG2a anti-VSG-induced 
release of sVSG from T. congolense more than fresh serum from BALB/c 
mice 
Aim 
To test the effect of fresh C57BL/6 serum and BALB/c serum on the release of sVSG 
from T. congolense by interaction with IgG2a anti-VSG 
Protocol 
1. 107 /ml T. congolense were mixed with IgG2a anti-VSG (mAb 1D11) (5 µg/ml 
or 2.5 µg/ml) and 50% fresh CD1 mouse serum in TSG. The mixtures were 
incubated at 370C different for 30 min, and then centrifuged at 13,000 x g at 40C 
for 15 min. The supernatants were collected. 
2. The sVSG in the supernatants were tested by western blot. Rabbit anti-T. 
congolense antiserum was used as first antibody, and peroxidase-labelled mouse 
anti-rabbit IgG (H+L) as second antibody.  
Results and conclusion 
Western blot results showed that more antibody-induced release of sVSG from T. 
congolense occurs in the presence of fresh C57BL/6 serum than in the presence of fresh 
BALB/c serum. These results indicate IgG2a anti-VSG-induced release of sVSG from T. 
congolense is affected by the source of complement. 
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Figure 8.6 
 
 
 
 
 
 
 
 
 
 
Figure 8.6 Fresh serum from C57BL/6 mice enhances IgG anti-VSG-induced 
release of sVSG from T. congolense more than fresh serum from BALB/c mice. T. 
congolense (107/ml) were incubated with different amount of IgG anti-VSG (mAb 1D11) 
and 50% fresh C57BL/6 serum or fresh BALB/c serum. The supernatants of the 
mixtures were tested for sVSG by Western blot (1# Ab: rabbit anti-T. congolense 
antiserum, 2# Ab: peroxidase-labelled mouse anti-rabbit IgG (H+L)). The band densities 
were measured by Alphaimager software.  
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8.7 Interaction of IgM anti-VSG and Trypanosoma congolense in the presence of 
complement: some of the shed sVSG is covalently bound to C3 fragments 
(sVSG-C3b)  
Aim 
To test whether sVSG being released from T. congolense covalently binds with C3 
fragment 
Protocol 
1. 108 /ml T. congolense were mixed with IgM anti-VSG antibody (25 µg/ml) and 
50% fresh mouse serum with or without 10mM EDTA. Fresh C57BL/6 serum or 
fresh BALB/c serum were used. The mixtures were incubated at 370C for 30 min, 
and then centrifuged at 13,000 x g at 40C for 15 min. The supernatants were 
collected. EDTA is chelating Ca++ and Mg++ and used as inhibitor of the 
complement cascade 
2. All supernatants were mixed with rabbit anti-T. congolense antiserum in the 
presence of 10 mM EDTA at RT for 1 hr. They were then centrifuged at 13,000 x 
g at 40C for 15 min. The precipitates were washed with PBS and then suspended 
in PBS/1% SDS. The precipitates were tested for C3 fragments by western blot 
(peroxidase-labelled goat anti-mouse C3), as well as for sVSG by western blot 
(1#: rabbit anti-T. congolense antiserum; 2#: peroxidase-labelled mouse anti-
rabbit IgG (H+L) 
Results and conclusion 
A band of molecular weight of about 210kD, corresponding to the size of C3b-VSG, 
was detected in the presence of fresh mouse serum without EDTA (A, lane 2 & 4) but 
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not in fresh mouse serum with 10mM EDTA (A, lane 3 & 5). A band of similar size was 
detected by rabbit anti-T. congolense antiserum in the presence of fresh mouse serum 
without use of EDTA (B, lane 2 & 4), but not in the presence of fresh mouse serum with 
10 mM EDTA (B, lane 3 & 5). These results indicate that some sVSG shed from T. 
congolense covalently binds with a C3 fragment. 
Figure 8.7 
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Figure 8.7 Interaction of IgM anti-VSG and Trypanosoma congolense in the 
presence of complement: some of the shed sVSG is covalently bound to C3 
fragments (sVSG-C3b). Immunoprecipitations by anti-T. congolense antiserums were 
carried out using the supernatants from the incubated mixtures of T. congolense (108/ml), 
IgM anti-VSG (mAb 6C1) (25 µg/ml) and 50% of fresh mouse serum with or without 10 
mM EDTA. Fresh mouse sera from C57BL/6 or BALB/c mice were used. The 
precipitates from the immunprecipitation were tested for C3 fragments by western blot 
(peroxidase-labelled goat anti-mouse C3 IgG [Cappel]) (A), and tested for sVSG by 
western blot (1# Ab: rabbit anti-T. congolense antiserum, 2# Ab: peroxidase-labelled 
mouse anti-rabbit IgG (H+L)) (B). 
Lane 1: BenchMark prestained protein ladder;  
Lane 2: fresh C57BL/6 serum+ T. congolense + IgM anti-VSG;  
Lane 3: fresh C57BL/6 serum + 10mM EDTA+ T. congolense+ IgM anti-VSG;  
Lane 4: fresh BALB/c serum + T. congolense+ IgM anti-VSG;  
Lane 5: fresh BALA/c serum + 10mM EDTA+ T. congolense+ IgM anti-VSG;  
Lane 6: partly purified sVSG. 
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8.8 Parasitemia in CD11b-deficient and normal C57BL/6 mice infected with 
Trypanosoma congolense  
Aim 
To test the role of CR3-mediated phagocytosis of T. congolense in controlling 
parasitemia in vivo 
Protocol 
1. 5 female 10 to 12 week-old CD11b-deficient mice and 4 female 10 to 12 week-
old normal C57BL/6 mice were injected with 103 T. congolense.  
2. The parasitemia was estimated by examining a drop of blood from the tail vein 
on a microscopic slide at 400x magnification by phase contrast microscopy.  
Result and conclusion 
CD11b-deficient mice control the first parasitemia earlier than normal C57BL/6 mice. 
At day 7-post infection, CD11b-deficient mice showed significant lower parasitemia 
than normal mice. These data suggest that CR3-deficience might weakly enhance, rather 
than decrease, the control of parasitemia in T. congolense infection. 
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Figure 8.8 
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Figure 8.8 Parasitemia in CD11b-deficient mice and normal mice infected with 
Trypanosoma congolense. 5 female 10 to 12 week-old CD11b-deficient mice and 4 
female 10 to 12 week-old normal C57BL/6 mice were injected with 103 T. congolense 
(ip.). The parasitemia was estimated by examining a drop of blood from the tail vein on 
a microscopic slide at 400× power by phase contrast microscopy. * On day 7, the 
parasitemia in CD11b-deficient mice was significantly lower than in normal C57BL/6 
mice (10.92±2.82 vs. 24.35±0.35, respectively) (p=0.005). 
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